Malignant neoplasm of digestive organs, including Hilmo

C3_DIGESTIVE_ORGANS_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints C3_OESOPHAGUS_WIDE C3_STOMACH_WIDE C3_SMALL_INTESTINE_WIDE C3_COLON_WIDE C3_RECTOSIGMOID_JUNCTION_WIDE C3_RECTUM_WIDE C3_ANUS_ANALCANAL_WIDE C3_BILIARY_GALLBLADDER_WIDE C3_PANCREAS_WIDE C3_DIGESTIVE_ORGANS_NAS_WIDE	26562
6. Filter based on genotype QC (FinnGen only)	23768

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF14

NAME	C3_DIGESTIVE_ORGANS_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_OESOPHAGUS_WIDE\|C3_STOMACH_WIDE\|C3_SMALL_INTESTINE_WIDE\|C3_COLON_WIDE\|C3_RECTOSIGMOID_JUNCTION_WIDE\|C3_RECTUM_WIDE\|C3_ANUS_ANALCANAL_WIDE\|C3_BILIARY_GALLBLADDER_WIDE\|C3_PANCREAS_WIDE\|C3_DIGESTIVE_ORGANS_NAS_WIDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of digestive organs, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	23768	9785	13983
Unadjusted period prevalence (%)	5.20	3.47	6.41
Median age at first event (years)	69.74	68.79	70.40

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
23280: Matched controls
171066

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J01MA12

ATC

levofloxacin; systemic

2.0

323.3

4625

18959

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

323.3

350

WZC15, ,

NOMESCO Finland

29.9

323.0

270

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.7

320.3

477

412

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

317.1

343

L02BB03

ATC

bicalutamide; oral

869.8

316.9

350

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

316.1

342

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

47.7

315.5

238

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.4

313.5

898

1547

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

5.8

313.4

659

856

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

313.4

339

SPAT1125

SPAT

Stoma care and guidance

5.5

312.1

688

937

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

310.6

336

D76

ICPC

Malignant neoplasm pancreas

292.1

310.3

354

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

1302.5

307.8

338

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

50.6

307.7

1072

163

3018

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

483

369

Kela drug reimbursment

Regorafenib

+∞

307.7

365

JFB30

NOMESCO Finland

Right hemicolectomy

44.6

307.7

1555

274

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

352.5

307.7

1608

JN4CD

NOMESCO Finland

Very extensive body CT

17.6

307.7

2088

954

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

307.7

454

A03FA01

ATC

metoclopramide; systemic, rectal

13.5

307.7

11396

11373

WX408

NOMESCO Finland

General anesthesy, balanced

2.9

307.7

7298

23523

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

241.6

307.7

388

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3900.0

307.7

2852

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

5220.2

307.7

2566

UJK02

NOMESCO Finland

ERCP

7.1

307.7

1518

1674

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

11.2

307.7

987

674

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

3117.3

307.7

424

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

307.7

521

L01BC59

ATC

trifluridine, combinations; systemic

+∞

307.7

517

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

307.7

4228

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

11.5

307.7

975

650

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.8

307.7

548

232

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

5909.7

307.7

785

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

1326.9

307.7

551

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.8

307.7

3027

4296

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

15.1

307.7

1473

761

JG1CG

NOMESCO Finland

Extensive MRI of rectum

100.8

307.7

731

A04AA01

ATC

ondansetron; systemic, rectal

14.4

307.7

3707

2227

D70.82

ICD-10 Finland

Drug-induced neutropenia

18.8

307.7

440

175

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

307.7

897

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

307.7

2506

7689

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.0

307.7

2274

5927

JKA20

NOMESCO Finland

Cholecystectomy

4.1

307.7

1026

1911

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

25.4

307.7

348

102

K83.1

ICD-10 Finland

Obstruction of bile duct

18.8

307.7

1184

487

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

18.2

307.7

579

240

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

25.4

307.7

773

231

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

3028.0

307.7

811

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

20.4

307.7

3302

1374

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

270.5

307.7

398

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

617

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

2853

H01CB03

ATC

lanreotide; parenteral

185.7

307.7

373

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

307.7

574

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

17.3

307.7

1286

575

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

307.7

425

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

6.3

307.7

791

957

JFF23

NOMESCO Finland

Transversostomy

57.6

307.7

1290

174

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

7.8

307.7

917

894

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

6.1

307.7

845

1055

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

43.9

307.7

1007

176

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

307.7

987

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

7.9

307.7

903

864

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

4407.0

307.7

1694

A79

ICPC

Malignancy NOS

180.9

307.7

785

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

307.7

773

JN3AD

NOMESCO Finland

Abdominal CT examination

4.1

307.7

5424

11701

HAC20

NOMESCO Finland

Total mastectomy

131.3

307.7

421

UJG02

NOMESCO Finland

Proctoscopy

5.8

307.7

1008

1332

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

707.2

307.7

2569

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

111.9

307.7

1295

JDD00

NOMESCO Finland

Total gastrectomy and Roux-en-Y oesophagojejunostomy

472.2

307.7

380

WF049

NOMESCO Finland

Radiotherapy of metastasis

1103.7

307.7

1411

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

18.4

307.7

1114

465

TPX10

NOMESCO Finland

Implantation of vascular injection port

12.5

307.7

1839

1162

JLC30

NOMESCO Finland

Pancreatoduodenectomy

91.2

307.7

710

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

11.0

307.7

588

402

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

218.3

307.7

1501

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

9.6

307.7

998

795

A06AH03

ATC

naloxegol; oral

23.6

307.7

762

245

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

940.6

307.7

378

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

307.7

573

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

34.9

307.7

392

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

495.3

307.7

528

R18

ICD-10 Finland

Ascites

8.4

307.7

945

859

ZX080

NOMESCO Finland

Image guided radiotherapy

695.7

307.7

373

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

137.6

307.7

241

WF003

NOMESCO Finland

Adjuvant radiotherapy

217.3

307.7

605

Y77

ICPC

Malignant neoplasm prostate

130.5

307.7

453

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

32.3

307.7

278

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.8

307.7

1607

3294

A04AA02

ATC

granisetron; systemic, transdermal

994.0

307.7

5323

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

307.7

367

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.0

307.7

355

106

WF004

NOMESCO Finland

Palliative radiotherapy

857.8

307.7

790

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

940.5

307.7

1664

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

307.7

446

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

1585.1

307.7

438

JFB00

NOMESCO Finland

Partial resection of small intestine

11.3

307.7

1062

723

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

390.4

307.7

367

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

8.3

307.7

675

615

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

6168.9

307.7

1582

WF002

NOMESCO Finland

Radical radiotherapy

95.6

307.7

1645

136

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

307.7

1999

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

992.8

307.7

397

JFF10

NOMESCO Finland

Loop enterostomy

31.3

307.7

472

113

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.1

307.7

3797

10027

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

6.3

307.7

4686

6599

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

102.9

307.7

345

JN4AD

NOMESCO Finland

Body CT examination

13.0

307.7

7009

5499

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

89.3

307.7

1806

161

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

307.7

771

B01AB04

ATC

dalteparin; parenteral

3.8

307.7

1729

3495

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

9.8

307.7

3971

3521

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

307.7

760

L02BG04

ATC

letrozole; oral

25.6

307.7

684

202

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

41.9

307.7

426

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

18.1

307.7

369

152

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

12054

61221

TPH07

NOMESCO Finland

Cathetrisation of artery

4.5

307.7

4927

9573

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

307.7

1598

WF001

NOMESCO Finland

Preoperative radiotherapy

4834.5

307.7

1261

WX302

NOMESCO Finland

Thoracal epidural anesthesy

28.3

307.7

4998

1639

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.3

307.7

1275

1548

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

307.7

547

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

154.4

307.7

270

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

119.2

307.7

383

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

5.7

307.7

1520

2083

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

16.3

307.7

1278

606

L03AA02

ATC

filgrastim; parenteral

159.8

307.7

1118

JFB43

NOMESCO Finland

Left hemicolectomy

21.9

307.7

450

154

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

307.7

1360

JN4BD

NOMESCO Finland

Extensive body CT

15.3

307.7

5894

3720

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

307.7

1825

N02AA05

ATC

oxycodone; systemic

5.7

307.7

8468

15681

Z51.5

ICD-10 Finland

Palliative care

17.9

307.7

6120

3343

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

307.7

955

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

5607.1

307.7

1448

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

69.1

307.7

515

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

307.7

393

UJF32

NOMESCO Finland

Coloscopy

4.2

307.7

10864

29633

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

307.7

726

A06AD11

ATC

lactulose; oral

2.1

307.7

4140

16257

WZC30

NOMESCO Finland

Teaching

4.4

307.7

5995

12598

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

3223.9

307.7

438

TJF80

NOMESCO Finland

Ostomy education

34.4

307.7

936

208

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

307.7

4008

11359

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.1

307.7

1219

1831

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

307.7

353

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

16386

94909

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

11.0

307.7

1697

1218

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.4

307.7

3070

7295

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.6

307.7

3742

11582

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

307.7

403

D64.9

ICD-10 Finland

Anaemia, unspecified

2.4

307.7

3390

11543

JAL30

NOMESCO Finland

Omentectomy

18.5

307.7

354

143

R4110

NOMESCO Finland

Physiotherapy

1.9

307.7

6724

29718

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

307.7

4999

18983

XX3DW

NOMESCO Finland

Time consuming IT work

7.4

307.7

3183

3574

B01AB05

ATC

enoxaparin; parenteral

3.7

307.7

10967

33085

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.1

307.7

4165

15957

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

307.7

669

R4190

NOMESCO Finland

Nutritional therapy

7.8

307.7

1701

1719

ZX120

NOMESCO Finland

Intravenous

4.0

307.7

2941

5911

L01BC06

ATC

capecitabine; oral

+∞

307.7

6445

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

16384.0

307.7

2612

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

3805.1

307.7

514

C16.00

ICD-10 Finland

Cardia

2669.3

307.7

365

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

1261.6

307.7

490

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

6460

22848

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

16384.0

307.7

2191

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

690.0

307.7

370

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.8

307.7

3633

7882

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.9

307.7

1525

3036

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

48.5

307.7

1047

166

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

883.7

307.7

1035

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

753.6

307.7

600

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

884.5

307.7

472

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

4224.1

307.7

1111

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

307.7

420

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

26.9

307.7

466

130

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

33.0

307.7

423

H02AB02

ATC

dexamethasone; systemic

75.2

307.7

6737

922

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

307.7

962

L02BA01

ATC

tamoxifen; oral

62.3

307.7

351

C61

ICD-10 Finland

Malignant neoplasm of prostate

337.0

307.7

1701

WZC00

NOMESCO Finland

Treatment plan or consultation

3.3

307.7

10269

32878

WX402

NOMESCO Finland

General anaesthesia

3.3

307.7

6684

18803

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.2

307.7

792

733

D75

ICPC

Malignant neoplasm colon/rectum

260.7

307.7

1147

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

11261

115

Kela drug reimbursment

Breast cancer

+∞

307.7

960

A04AA55

ATC

palonosetron, combinations; systemic

4801.7

307.7

1253

H01CB02

ATC

octreotide; parenteral

65.2

307.7

298

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

2387.6

307.7

647

WW500

NOMESCO Finland

Blood transfusion

9.7

307.7

1569

1264

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

23.7

307.7

956

309

XX2RW, ,

NOMESCO Finland

10.7

307.7

485

341

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

66.0

307.7

501

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

88.5

307.7

564

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

30.1

307.7

419

104

176

Kela drug reimbursment

Regorafenib

+∞

307.7

376

116

Kela drug reimbursment

Prostate cancer

+∞

307.7

974

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

307.7

431

L02AE02

ATC

leuprorelin; implant, parenteral

26.4

307.7

678

194

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

7.1

307.7

1804

1998

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

250.4

307.7

822

C20

ICD-10 Finland

Malignant neoplasm of rectum

5225.3

307.7

1356

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

18.1

307.7

2312

1036

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

20.9

307.7

304

108

A04AD12

ATC

aprepitant; systemic

800.6

307.7

739

K56.7

ICD-10 Finland

Ileus, unspecified

6.0

307.7

789

993

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

223.9

307.7

360

ZX070

NOMESCO Finland

Intensity modified radiotherapy

498.2

307.7

531

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

48.7

307.7

301

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

22.1

307.7

373

126

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

8988

35076

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

1033.9

307.7

679

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.0

307.7

1035

1325

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

307.7

902

JFB46

NOMESCO Finland

Resection of sigmoid colon

9.2

307.7

597

490

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.9

307.7

1506

3017

K83.0

ICD-10 Finland

Cholangitis

6.5

307.7

692

804

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

39.3

307.7

270

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

10.2

307.7

455

334

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

27.5

307.7

862

239

R50.9

ICD-10 Finland

Fever, unspecified

2.4

307.7

3782

13034

ZX090

NOMESCO Finland

Other technic of radiotherapy

238.4

307.7

662

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

307.7

1076

WX600

NOMESCO Finland

Single shot through catheter

22.4

307.7

950

324

PJA12

NOMESCO Finland

Sentinel node biopsy

379.9

307.7

895

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

2078.6

307.7

567

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

307.7

547

D77

ICPC

Malignant digestive neopl other/NOS

310.3

307.7

496

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

56.6

307.7

289

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1898.2

307.7

3876

KCD02

NOMESCO Finland

Transurethral resection of bladder

13.4

307.7

391

218

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4971.5

307.7

665

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

307.7

655

JAH00

NOMESCO Finland

Laparotomy

8.0

307.7

1493

1447

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

24.6

307.7

425

129

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

307.7

767

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

5057.1

307.7

676

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

307.7

1249

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

307.7

364

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4120.3

307.7

555

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

9.5

307.7

2309

1964

ZXC96

NOMESCO Finland

Robot assisted procedure

15.3

307.7

545

267

L03AA13

ATC

pegfilgrastim; parenteral

1720.2

307.7

1152

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

307.7

505

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

2780.9

307.7

748

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

115.7

307.7

326

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

7.1

307.7

1094

1186

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

69.1

307.7

560

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

307.7

3631

B01AB10

ATC

tinzaparin; parenteral

4.7

307.7

4099

7493

JMA10

NOMESCO Finland

Transabdominal total splenectomy

22.3

307.7

305

102

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

316.9

307.7

465

1506

Kela drug reimbursment

The combination of trifluridine and tipiracil

+∞

307.7

487

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

307.7

1059

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

12.3

307.7

1042

650

JG1BG

NOMESCO Finland

MRI of rectum

157.2

307.7

905

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

5.9

307.7

813

1051

Z93.3

ICD-10 Finland

Colostomy status

39.2

307.7

784

152

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

307.7

512

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

57.9

307.7

836

110

JAH01

NOMESCO Finland

Laparoscopy

5.7

307.7

1680

2306

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

307.7

875

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

419.1

300.4

338

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

1254.4

297.6

327

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

25.5

295.0

258

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

294.9

7860

38972

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

11.6

290.6

357

229

K92.1

ICD-10 Finland

Melaena

2.7

290.5

1750

4920

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

92.6

289.4

200

JGB10

NOMESCO Finland

Partial proctectomy and end colostomy

51.4

288.7

215

JN6AD

NOMESCO Finland

CT of torso and neck

9.6

285.9

397

310

107

Kela drug reimbursment

Pernicious anaemia

4.5

285.9

800

1351

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

129.3

285.5

192

JFB54

NOMESCO Finland

Laparoscopic resection of sigmoid colon with partial proctectomy

42.7

284.4

219

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

8.6

283.7

426

372

JLC10

NOMESCO Finland

Distal pancreatectomy

33.5

283.2

230

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

282.8

306

JDE00

NOMESCO Finland

Gastrojejunostomy

60.8

282.4

205

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

281.9

305

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

281.9

305

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

281.1

8109

40958

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

280.0

303

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.2

272.5

832

1507

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

272.2

2624

9196

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

271.7

294

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

269.8

292

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.9

266.4

1404

3663

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

36.2

263.4

210

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

261.6

1545

4292

Z51.0

ICD-10 Finland

Radiotherapy session

314.5

261.2

297

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

43.6

260.7

200

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.8

260.6

244

JJB10

NOMESCO Finland

Atypcal resection of liver

275.8

260.6

298

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

12.4

259.1

306

183

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

258.9

1740

5167

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

32.6

258.1

211

C50.99

ICD-10 Finland

Breast, unspecified

310.2

257.5

293

ZZR00

NOMESCO Finland

Flap of skin

8.8

257.4

378

320

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

255.9

277

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

255.4

1330

3445

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

255.0

276

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

252.2

273

Z43.3

ICD-10 Finland

Attention to colostomy

37.1

252.1

200

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

9.6

249.9

345

267

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.2

245.8

485

589

C16.0

ICD-10 Finland

Malignant neoplasm: Cardia

+∞

244.8

265

Z93

ICD-10 Finland

Artificial opening status

30.7

244.6

203

WPB10

NOMESCO Finland

Making a convalescent care decision

23.5

244.1

219

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

62.0

243.1

176

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

6.1

242.5

482

590

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

49.6

241.6

181

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

11.2

241.2

302

200

TPX15

NOMESCO Finland

Removal of vascular injection port

18.2

239.7

236

ZX121

NOMESCO Finland

Central venous catheter

28.4

239.5

203

Z31.5

ICD-10 Finland

Genetic counselling

3.5

239.0

928

2001

HA1AA

NOMESCO Finland

X-ray mammography

3.4

237.0

984

2218

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

20.4

236.6

223

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

236.5

256

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

1855.5

235.0

257

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

234.6

254

XX1AD

NOMESCO Finland

Other CT-examination

65.4

233.7

168

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

14.7

232.9

252

127

WX704

NOMESCO Finland

Intubation

2.3

232.7

1982

6566

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

231.5

1278

3417

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

9.9

231.2

314

237

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

10.5

229.1

299

212

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.5

228.9

1645

5038

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

241.8

227.7

262

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

227.2

2763

10564

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

227.2

246

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.3

224.5

379

385

C16.09

ICD-10 Finland

Malignant tumor of cardiac or other unspecified carcinoma

+∞

224.4

243

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

6.3

223.5

432

513

E34.0

ICD-10 Finland

Carcinoid syndrome

214.0

222.6

258

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

221.6

1067

2636

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

220.7

239

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

220.7

239

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

219.8

238

C18.9

ICD-10 Finland

Malignant neoplasm: Colon, unspecified

+∞

219.8

238

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

894.2

218.2

241

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.2

218.2

260

158

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

218.0

236

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

215.2

233

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

3.0

213.9

1079

2739

L02BG03

ATC

anastrozole; oral

43.1

212.0

163

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

8.8

211.9

311

263

N02AX02

ATC

tramadol; systemic, rectal

1.6

211.7

9860

54926

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

+∞

211.5

229

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.1

208.9

656

1213

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

1638.4

208.2

228

N02AA01

ATC

morphine; systemic, rectal

4.7

208.1

542

860

C16.2

ICD-10 Finland

Malignant neoplasm: Body of stomach

+∞

207.8

225

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

224.1

207.6

240

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

1630.9

207.3

227

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

205.9

223

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.8

205.1

1159

3135

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

205.0

222

198

Kela drug reimbursment

Sorafenib

+∞

204.1

221

R11

ICD-10 Finland

Nausea and vomiting

2.2

203.2

2058

7317

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

203.1

220

8145/3-C16.9

ICD-O-3

Carcinoma, diffuse type of stomach, NOS

+∞

203.1

220

C18.91

ICD-10 Finland

Malignant tumor of unspecified location in colon invasive carcinoma

+∞

202.2

219

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

9.7

202.1

277

212

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

201.3

218

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

57.2

200.6

147

1XC07, ,

NOMESCO Finland

1571.1

199.9

219

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

199.4

216

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

35.6

198.7

159

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

198.5

215

JWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery

23.5

198.4

178

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

197.6

214

8140/3-C18.3

ICD-O-3

Adenocarcinoma, NOS, of hepatic flexure of colon

+∞

197.6

214

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

196.7

213

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

195.7

212

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

195.7

7932

42607

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.8

194.8

1077

2877

JFB50

NOMESCO Finland

Other resection of colon

17.9

194.5

193

ZXD05

NOMESCO Finland

Urgent procedure

1.6

194.2

6413

32833

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.7

194.1

510

815

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

193.0

209

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

192.1

1516

4840

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

192.0

208

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

45.0

191.4

146

ZX050

NOMESCO Finland

Stereotactic radiotherapy

25.2

190.3

167

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

190.2

206

JG1DG

NOMESCO Finland

Very extensive MRI of rectum

81.9

190.0

133

ZX112

NOMESCO Finland

Subcutaneous

6.8

188.9

341

375

C16.23

ICD-10 Finland

Malignant tumor of the corpus ventriculi diffuse carcinoma

+∞

188.3

204

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

59.6

188.1

137

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

45.6

186.7

142

L01BC53

ATC

tegafur, combinations; systemic

+∞

185.6

201

TJA10

NOMESCO Finland

Laparocentesis

28.8

184.9

156

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.0

184.7

448

667

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

37.2

184.2

146

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

6.0

184.0

373

466

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

183.7

199

Z43.2

ICD-10 Finland

Attention to ileostomy

32.4

182.0

149

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

182.0

2527

10080

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.8

181.8

623

1229

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

7.3

181.6

306

310

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

64.0

180.3

130

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

180.0

195

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.8

179.1

613

1208

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

17.4

178.6

179

L01AX03

ATC

temozolomide; systemic

+∞

178.2

193

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.0

177.1

168

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

177.0

1458

4741

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.0

176.6

879

2211

C03CA01

ATC

furosemide; systemic

1.5

175.9

7821

42621

JFB40

NOMESCO Finland

Resection of transverse colon

32.3

175.7

144

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

66.5

175.6

126

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

59.1

175.5

128

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

175.4

190

D99

ICPC

Disease digestive system other

5.4

175.4

393

543

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

8.5

174.9

262

228

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.1

173.4

807

1950

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

31.8

172.7

142

WX002

NOMESCO Finland

Sedation and analgesia

1.7

171.5

4303

20466

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

3.1

170.2

817

2011

C50

ICD-10 Finland

Malignant neoplasm of breast

209.4

169.8

197

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.5

169.3

1245

3842

WPA13

NOMESCO Finland

Palliative consultation

12.5

169.2

199

118

L01EX05

ATC

regorafenib; oral

+∞

168.9

183

128

Kela drug reimbursment

Cancers of female genital organs

352.7

168.8

191

JGB37

NOMESCO Finland

Laparoscopic wide excision of rectum

1317.6

168.6

185

Z3231

NOMESCO Finland

Registered nurse

1.6

166.3

5647

28907

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

345.2

165.1

187

JFF24

NOMESCO Finland

Laparoscopic transversostomy

50.5

164.6

123

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

16.5

164.5

169

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

164.3

178

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

229.2

162.1

187

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

665.9

162.0

180

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.8

160.4

540

1051

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

47.0

159.9

121

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

228.6

159.4

184

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

158.9

942

2609

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.9

158.4

809

2064

8140/3-C15.9

ICD-O-3

Adenocarcinoma, NOS, of esophagus, NOS

+∞

157.8

171

8240/3-C17.9

ICD-O-3

Neuroendocrine tumor, NOS, of small intestine, NOS

+∞

156.9

170

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

156.9

170

C16.20

ICD-10 Finland

Malignant tumor of the corpus ventriculi without histology

+∞

156.9

170

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

53.5

156.7

116

JF2AB

NOMESCO Finland

Colongraphy with X-ray

15.8

156.6

164

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

643.5

156.5

174

8000/3-C25.0

ICD-O-3

Neoplasm, malignant of head of pancreas

+∞

156.0

169

8240/3-C18.1

ICD-O-3

Neuroendocrine tumor, NOS, of appendix

+∞

156.0

169

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

155.9

751

1852

XW000

NOMESCO Finland

Bone marrow biopsy

3.2

155.3

678

1574

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

68.3

155.2

111

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.6

155.1

997

2879

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

155.1

168

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

155.1

168

JJA20

NOMESCO Finland

Open biopsy of liver

18.6

154.7

151

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.6

154.7

230

198

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

154.0

1011

2950

E0000UV, ,

ATC

1.5

153.8

8620

48891

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.0

153.6

493

926

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

12.4

153.4

181

108

WX892

NOMESCO Finland

Monitored bed care

2.0

150.9

1812

6844

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

5.0

150.7

369

554

C16.29

ICD-10 Finland

Malignant tumor of the corpus ventriculi other or unspecified carcinoma

+∞

150.4

163

X76

ICPC

Malignant neoplasm breast female

215.8

150.3

174

J01MA02

ATC

ciprofloxacin; systemic

1.5

150.0

8552

48600

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

149.6

3219

36209

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

149.5

162

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

12.0

149.3

179

110

189

Kela drug reimbursment

Imatinib

1250.0

149.2

164

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

21.5

148.3

137

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.4

148.0

593

1303

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

161.0

147.6

174

C16.3

ICD-10 Finland

Malignant neoplasm: Pyloric antrum

+∞

146.7

159

C16.39

ICD-10 Finland

Malignant tumor of the antrum ventriculi other or unspecified carcinoma

+∞

146.7

159

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

146.7

159

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

146.7

159

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.6

146.7

313

412

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

146.5

3610

17013

JFB20

NOMESCO Finland

Ileocaecal resection

8.9

146.4

213

178

SPAT1262

SPAT

Handing over of treatment supplies

1.6

146.0

4075

19816

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

145.8

158

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

5.8

145.5

301

384

JDA55

NOMESCO Finland

Endoscopic dilatation of stomach, pylorus or anastomosis of stomach

14.7

145.2

157

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

28.4

145.2

123

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

144.9

157

WPA44, ,

SPAT

13.5

144.8

163

B81

ICPC

Anaemia vit B12/folate deficiency

2.5

144.7

1063

3274

L01XE21

ATC

[U] regorafenib

+∞

144.0

156

Z93.2

ICD-10 Finland

Ileostomy status

10.7

143.9

185

128

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

10.6

143.8

186

130

C10AA07

ATC

rosuvastatin; oral

0.6

143.6

4658

47801

WW200, ,

SPAT

0.6

143.6

3719

40106

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

143.2

495

982

8140/3-C15.5

ICD-O-3

Adenocarcinoma, NOS, of lower third of esophagus

+∞

143.0

155

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.4

142.3

1148

3690

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

1181.5

141.8

156

JGB36

NOMESCO Finland

Wide excision of rectum

583.8

141.8

158

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.8

141.5

296

382

L02AE04

ATC

triptorelin; parenteral

46.5

141.1

107

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.9

141.0

205

171

V03AF03

ATC

calcium folinate; systemic

238.2

140.8

162

C209, 8148, 2

ICD-O-3

21.0

140.6

131

S77

ICPC

Malignant neoplasm of skin

16.4

139.9

144

JDC20

NOMESCO Finland

Partial gastrectomy and Roux-en-Y reconstruction

30.6

139.7

116

JDC10

NOMESCO Finland

Partial gastrectomy and gastrojejunostomy

51.2

139.4

104

178

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

139.3

151

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

139.3

151

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.8

139.2

352

544

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

138.4

150

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

41.6

138.2

107

ZXE00

NOMESCO Finland

One hour or less

1.5

138.0

7608

42771

A98

ICPC

Health maint/preventive medicine

0.6

138.0

18772

148344

C16.30

ICD-10 Finland

Malignant tumor of the antrum ventriculi without histology

+∞

137.5

149

JJB71

NOMESCO Finland

Laparoscopic resection of liver

196.5

136.7

159

8240/3-C18.2

ICD-O-3

Neuroendocrine tumor, NOS, of ascending colon

+∞

136.6

148

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

31.8

136.2

112

T73

ICPC

Neoplasm endocrine other/unspecified

31.8

136.2

112

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

17.8

136.0

135

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

195.3

135.8

158

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

35.0

135.6

109

JFB53

NOMESCO Finland

Resection of sigmoid colon with partial proctectomy

42.6

134.9

104

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

15.3

134.9

143

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

134.7

146

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

1113.6

134.5

148

KC1GB

NOMESCO Finland

Cystography with X-ray

16.6

133.9

137

8263/2-C20.9

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of rectum, NOS

18.1

133.7

132

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

9.1

133.4

191

156

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

64.4

133.1

JDA63

NOMESCO Finland

Local excision of lesion of stomach

20.5

133.0

125

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

132.9

144

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

546.5

132.6

148

JFF27

NOMESCO Finland

Laparoscopic sigmoidostomy

28.5

132.3

112

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

132.0

143

A28

ICPC

Limited function/disability NOS

1.6

131.8

4351

21953

C25

ICD-10 Finland

Malignant neoplasm of pancreas

276.0

131.3

150

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

131.0

142

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

131.0

142

D37.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Appendix

11.8

130.9

159

100

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.5

130.6

921

2780

JJB30

NOMESCO Finland

Excision of two segments of liver

187.6

130.3

152

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

130.1

141

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

129.3

1667

6446

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

13.8

129.3

144

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

4.0

129.1

410

764

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

6.8

127.7

229

250

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

14.5

127.6

139

C16.04

ICD-10 Finland

Malignant tumor of cardiac intestinal carcinoma

+∞

127.3

138

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

126.4

137

8480/3-C20.9

ICD-O-3

Mucinous adenocarcinoma of rectum, NOS

+∞

125.5

136

L01XE01

ATC

[U] imatinib

+∞

125.5

136

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

1029.5

125.2

138

WGA11

NOMESCO Finland

Planning of pain management

7.6

124.8

203

197

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

124.6

135

C15.1

ICD-10 Finland

Malignant neoplasm: Thoracic part of oesophagus

+∞

124.6

135

OAA41

NOMESCO Finland

Health check based on individual needs

41.7

124.0

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

343.9

123.7

140

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

123.6

134

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

1012.7

123.4

136

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

17.5

122.9

123

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

122.7

133

JN4DD

NOMESCO Finland

Scout CT scan of torso

51.6

122.1

8140/3-C18.5

ICD-O-3

Adenocarcinoma, NOS, of splenic flexure of colon

+∞

121.8

132

OAB43, ,

SPAT

0.5

121.8

1461

19458

TQW99

NOMESCO Finland

Other minor procedure on skin

2.5

121.7

849

2549

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

4.8

121.5

310

483

L02BX02

ATC

degarelix; parenteral

+∞

120.9

131

8480/3-C18.0

ICD-O-3

Mucinous adenocarcinoma of cecum

+∞

120.9

131

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

42.9

120.8

D74

ICPC

Malignant neoplasm stomach

207.8

120.8

140

WX610

NOMESCO Finland

Patient controlled analgesia

6.9

120.7

212

226

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

59.0

120.6

8240/3-C17.2

ICD-O-3

Neuroendocrine tumor, NOS, of ileum

+∞

119.9

130

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

119.9

130

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

494.4

119.8

134

WX004

NOMESCO Finland

Patient-controlled sedation

6.5

119.5

221

250

WVA20

NOMESCO Finland

Medicine administration

2.8

119.2

667

1789

C15.3

ICD-10 Finland

Malignant neoplasm: Upper third of oesophagus

971.1

118.8

131

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

971.1

118.8

131

Z3226

NOMESCO Finland

Physiotherapist

1.6

118.6

3614

17851

JFF13

NOMESCO Finland

Terminal enterostomy

12.1

118.6

142

C21.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of rectum, anus and anal canal

+∞

118.1

128

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

118.1

128

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.4

117.9

328

550

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

49.9

117.5

WPA43, ,

SPAT

21.5

116.9

108

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

946.3

116.0

128

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

10.7

116.0

149

103

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

321.5

115.4

131

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.3

115.4

487

1106

C16.03

ICD-10 Finland

Malignant tumor of cardiac diffuse carcinoma

+∞

115.3

125

C16.4

ICD-10 Finland

Malignant neoplasm: Pylorus

+∞

115.3

125

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

475.8

115.2

129

SPAT1255

SPAT

Intravenous administration of medicine

1.9

113.9

1514

5909

L02BG06

ATC

exemestane; oral

923.0

113.3

125

M01AH05

ATC

etoricoxib; oral

0.7

113.1

9519

83490

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

13.6

113.1

127

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

4.3

113.1

326

563

WX882

NOMESCO Finland

High dependency care

2.7

112.9

673

1867

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

314.0

112.7

128

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

112.6

122

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

25.8

112.5

K65.0

ICD-10 Finland

Acute peritonitis

4.0

111.6

351

649

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

111.6

121

C18.6

ICD-10 Finland

Malignant neoplasm: Descending colon

+∞

111.6

121

UJF34

NOMESCO Finland

Left colonoscopy

5.3

111.4

254

357

L01XE05

ATC

[U] sorafenib

+∞

110.7

120

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

7.2

110.6

189

195

UKC02

NOMESCO Finland

Cystoscopy

1.6

110.5

3267

16000

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

39.6

109.9

JCC10

NOMESCO Finland

Transthoracic partial oesophagectomy without interposition

121.9

109.8

132

323

Kela drug reimbursment

Sorafenib

+∞

108.9

118

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

107.9

117

TQW20

NOMESCO Finland

Tatoe

19.2

107.9

104

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

5.3

106.5

242

339

C16.24

ICD-10 Finland

Malignant tumor of the corpus ventriculi intestinal carcinoma

+∞

106.1

115

JFF26

NOMESCO Finland

Sigmoidostomy

17.4

105.7

106

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

105.7

846

2705

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

36.4

105.5

Z85.0

ICD-10 Finland

Personal history of malignant neoplasm of digestive organs

10.0

105.4

141

104

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

105.2

114

C18.42

ICD-10 Finland

Malignant tumor of the transverse colon carcinoma of the adenoma

+∞

105.2

114

8240/3-C20.9

ICD-O-3

Neuroendocrine tumor, NOS, of rectum, NOS

+∞

105.2

114

C18.3

ICD-10 Finland

Malignant neoplasm: Hepatic flexure

856.2

105.0

116

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.5

103.9

719

2149

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

14.8

103.9

112

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

103.4

2493

11600

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

103.3

112

C16.34

ICD-10 Finland

Malignant tumor of the antrum ventriculi intestinal carcinoma

+∞

103.3

112

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.3

103.1

232

322

A41.9

ICD-10 Finland

Sepsis, unspecified

2.3

102.5

843

2728

C15.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oesophagus

+∞

102.4

111

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

423.7

102.4

115

N02BE01

ATC

paracetamol; systemic, rectal

1.5

102.2

19576

133299

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.9

102.1

335

640

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

101.5

110

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

101.1

1728

7304

M25.5

ICD-10 Finland

Pain in joint

0.7

101.1

3792

38425

Z2221

NOMESCO Finland

Medical doctor

1.4

100.8

5018

27346

C17.1

ICD-10 Finland

Malignant neoplasm: Jejunum

+∞

100.6

109

C18.39

ICD-10 Finland

Malignant tumor of flexura hepatica other or unspecified histology

+∞

100.6

109

L01CB01

ATC

etoposide; systemic

+∞

100.6

109

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

100.6

109

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

416.3

100.5

113

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

100.5

1555

6373

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.4

100.4

140

110

JAG41

NOMESCO Finland

Repair of stomal hernia, laparoscopic

41.1

100.4

K22.2

ICD-10 Finland

Oesophageal obstruction

4.2

100.3

297

524

JFC00

NOMESCO Finland

Entero-enterostomy

20.0

100.2

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.1

100.1

453

1075

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

25.0

100.0

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

98.7

107

8480/3-C18.2

ICD-O-3

Mucinous adenocarcinoma of ascending colon

+∞

98.7

107

A41.8

ICD-10 Finland

Other specified sepsis

3.0

98.0

486

1218

C10AX09

ATC

ezetimibe; oral

0.6

97.3

2035

23431

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.8

97.1

534

1418

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

4.7

97.0

249

390

B03XA02

ATC

darbepoetin alfa; parenteral

3.2

96.6

424

987

KA1FN

NOMESCO Finland

Isotope renography

6.5

96.6

179

203

C18.49

ICD-10 Finland

Malignant tumor of the transverse colon other or unspecified histology

+∞

95.9

104

C17.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of small intestine

+∞

95.9

104

EB1VA, ,

NOMESCO Finland

0.6

95.2

1665

20067

JFA70

NOMESCO Finland

Suture of small intestine

8.0

95.0

149

138

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

95.0

103

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

94.1

102

1CD01, ,

NOMESCO Finland

+∞

94.1

102

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

94.1

102

JFC10

NOMESCO Finland

Ileotransversostomy

47.6

93.9

C82.1

ICD-10 Finland

Follicular lymphoma grade II

386.5

93.2

105

C24.02

ICD-10 Finland

Common bile duct

+∞

93.2

101

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

+∞

93.2

101

L01EA01

ATC

imatinib; oral

+∞

93.2

101

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

93.1

4320

23183

JAL00

NOMESCO Finland

Biopsy of peritoneum

11.5

92.9

114

EB4VA, ,

NOMESCO Finland

0.5

92.9

1232

16035

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

50.9

92.3

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

92.2

100

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

92.2

100

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

92.2

100

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

10.3

92.0

121

I81

ICD-10 Finland

Portal vein thrombosis

7.0

91.8

160

169

N05CF01

ATC

zopiclone; oral

1.4

91.7

6829

39774

C15.0

ICD-10 Finland

Malignant neoplasm: Cervical part of oesophagus

+∞

91.3

L01XX05

ATC

hydroxycarbamide; oral

15.9

91.3

KCC10

NOMESCO Finland

Cystoprostatectomy

196.1

91.2

106

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.0

91.1

451

1129

JFF00

NOMESCO Finland

Catheter enterostomy

40.3

91.0

A10AB05

ATC

insulin aspart; parenteral

1.7

90.9

1710

7427

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

158.0

90.8

107

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.2

90.8

398

926

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.9

90.7

476

1232

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

90.5

1404

5754

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

90.4

1153

4428

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

737.4

90.3

100

XKD00

NOMESCO Finland

Uroflowmetry

1.5

89.8

2996

15018

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.6

89.8

164

183

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

89.5

C24.00

ICD-10 Finland

Hepatic duct

+∞

89.5

SAA02

NOMESCO Finland

Basic examination of mouth

0.8

89.4

9706

83343

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

367.9

88.6

100

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

31.7

88.6

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

88.5

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

88.5

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

88.5

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

22.1

88.5

JFC20

NOMESCO Finland

Other enterocolostomy

33.2

88.4

OAA67, ,

SPAT

0.5

88.4

777

11540

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

87.6

C18.62

ICD-10 Finland

Malignant tumor of the descending colon carcinoma of the adenoma

+∞

87.6

6404

FHL

Hemicolectomy on the right

16.8

87.6

YX9AW, ,

NOMESCO Finland

111.8

87.6

106

K43.5

ICD-10 Finland

Parastomal hernia without obstruction or gangrene

19.4

87.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

87.4

804

2727

Z94.4

ICD-10 Finland

Liver transplant status

8.0

87.3

137

127

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

11.2

87.2

109

SAA01

NOMESCO Finland

Simple examination of mouth

0.8

87.2

11145

93738

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

17.1

87.1

SPAT1153

SPAT

Removal of sutures

1.4

87.1

6155

35482

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

86.7

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

86.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

86.6

6532

38044

UJD02

NOMESCO Finland

Gastroscopy

2.0

86.5

1099

4214

D47.3

ICD-10 Finland

Essential (haemorrhagic) thrombocythaemia

38.5

86.4

D18

ICPC

Change in faeces/bowel movements

2.4

86.2

623

1900

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

700.3

85.7

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

6.9

85.6

151

162

JGB01

NOMESCO Finland

Laparoscopic partial proctectomy and colorectal or coloanal anastomosis

86.9

85.4

106

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

85.4

1908

8682

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.2

85.2

254

451

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

85.1

5342

49837

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

108.6

84.9

103

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

84.9

SPAT1088

SPAT

Blood transfusion

7.0

84.7

148

157

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

9.0

84.5

121

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

84.4

319

674

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

7.7

84.2

136

131

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

349.4

84.1

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.2

84.0

143

147

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

83.9

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

83.9

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

3.3

83.9

355

808

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

83.5

1398

5862

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

83.4

928

3391

6434

FHL

Anterior resection

16.3

83.4

L02BB04

ATC

enzalutamide; oral

+∞

83.0

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

83.0

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

83.0

R01AD58

ATC

fluticasone, combinations; nasal

0.6

83.0

2152

23682

WPA11

NOMESCO Finland

Developing a plan for palliative care

10.5

82.6

107

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.6

82.6

220

356

WPA44

NOMESCO Finland

Nursing home for palliative care

11.2

82.5

103

A10AE04

ATC

insulin glargine; parenteral

1.6

82.4

2198

10452

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

82.1

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.9

81.9

267

508

8480/1-C18.1

ICD-O-3

Low grade appendiceal mucinous neoplasm of appendix

26.2

81.8

SDA03

NOMESCO Finland

Periodontal treatment

0.7

81.6

5090

47621

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

81.6

349

800

Y83.2

ICD-10 Finland

Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

7.7

81.2

131

126

197

Kela drug reimbursment

Sunitinib

+∞

81.2

1541A

ICD-9 Finland

Malignant neoplasm of rectum, rectosigmoid junction and anus, Rectum[NEOPLASMA MALIG RECTI,INVASIIVINEN KARSINOOMA]

+∞

81.2

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

14.9

81.1

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.4

81.1

328

725

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

80.8

1023

3916

JFF30

NOMESCO Finland

Other colostomy

15.9

80.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

80.1

2570

12749

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.8

79.8

268

521

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.5

79.5

543

1612

C90.0

ICD-10 Finland

Multiple myeloma

330.8

79.5

N03AX16

ATC

[U] pregabalin

1.4

79.4

4654

25942

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

79.3

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

79.3

JDW97

NOMESCO Finland

Other laparoscopic operation on stomach or duodenum

31.9

79.0

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

0.7

78.9

5481

50504

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

78.4

8480/3-C18.7

ICD-O-3

Mucinous adenocarcinoma of sigmoid colon

+∞

78.4

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

78.4

Z2446

NOMESCO Finland

Social worker

1.9

77.8

1076

4244

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

633.6

77.4

WPA13, ,

SPAT

16.6

77.4

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.5

77.2

212

352

JGB20

NOMESCO Finland

Partial rectosigmoidectomy and abdominoperineal pull-through anastomosis

114.3

77.1

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

6.6

77.0

141

158

M03BX02

ATC

tizanidine; oral

0.8

76.9

9500

80929

B82

ICPC

Anaemia other/unspecified

2.3

76.7

662

2186

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

76.7

1233

5104

JJB20

NOMESCO Finland

Excision of single segment of liver

626.2

76.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

134.3

76.4

JA3CT

NOMESCO Finland

Cathetrisation of abdominal cavity with CT guidance

14.1

76.2

K92.0

ICD-10 Finland

Haematemesis

2.4

76.2

597

1890

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

75.9

1069

4241

K56.0

ICD-10 Finland

Paralytic ileus

3.6

75.8

279

579

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

75.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

75.6

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

75.5

1086

4338

6322

FHL

Gastrectomy (including Roux-Y)

39.5

75.3

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

7.1

75.3

130

136

JJC00

NOMESCO Finland

Allogenic transplantation of liver

9.5

75.1

104

JEA00

NOMESCO Finland

Appendectomy

1.9

74.7

1025

4031

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

29.0

74.7

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

74.7

L01EX08

ATC

lenvatinib; oral

+∞

74.7

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

6.1

74.6

146

176

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.0

74.2

230

421

A06AH05

ATC

naldemedine; oral

15.5

74.1

191

Kela drug reimbursment

Erlotinib

+∞

73.8

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

20.3

73.2

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

4.8

73.1

182

278

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

72.9

1498

6654

3019

Kela drug reimbursment

Lenvatinib

+∞

72.9

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

72.9

L01EX02

ATC

sorafenib; oral

+∞

72.9

316

Kela drug reimbursment

Imatinib

+∞

72.9

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

72.9

384

Kela drug reimbursment

Combination product containing tegafur, gimeracil and oteracil

+∞

72.9

JG1CM

NOMESCO Finland

Extensive MRI of rectum (more than 1.5 T)

108.2

72.6

KCD10

NOMESCO Finland

Partial cystectomy

33.4

72.5

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

21.5

72.4

SFA20

NOMESCO Finland

Two-surface restoration

0.8

72.0

8444

72685

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

71.9

G04CA02

ATC

tamsulosin; oral

1.4

71.9

5332

30796

GDC00

NOMESCO Finland

Lobectomy of lung

13.1

71.8

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.8

71.7

241

469

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

14.4

71.5

B80

ICPC

Iron deficiency anaemia

2.4

71.3

535

1660

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

154.9

71.3

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

154.9

71.3

R93.3

ICD-10 Finland

Abnormal findings on diagnostic imaging of other parts of digestive tract

5.2

71.2

164

233

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

71.1

984

3881

JDE01

NOMESCO Finland

Laparoscopic gastroenterostomy

125.4

71.0

1508

Kela drug reimbursment

Lenvatinib

+∞

71.0

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

71.0

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

71.0

M79.6

ICD-10 Finland

Pain in limb

0.8

71.0

6308

56359

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

70.7

3450

18578

S18

ICPC

Laceration/cut

1.3

70.4

9473

59414

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

293.7

70.4

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.7

70.2

182

288

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

70.1

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

69.9

436

1238

A21

ICPC

Risk factor for malignancy

25.0

69.3

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.6

69.2

147

193

C16.01

ICD-10 Finland

Malignant tumor in cardia early diffuse gastric carcinoma early diffuse gastric carcinoma

+∞

69.2

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

26.0

69.0

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

197.1

69.0

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

10.4

68.3

KAC10

NOMESCO Finland

Total nephrectomy with capsule

11.5

68.3

C18.5

ICD-10 Finland

Malignant neoplasm: Splenic flexure

+∞

68.2

C209, 8211, 2

ICD-O-3

14.9

68.1

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

194.6

68.1

L15

ICPC

Knee symptom/complaint

0.7

68.1

3156

31185

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.9

67.6

168

256

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

4.3

67.6

191

325

JWW96

NOMESCO Finland

Other reoperation in gastroenterological surgery

8.7

67.4

D82

ICPC

Teeth/gum disease

0.7

67.4

4409

41237

Z01.2

ICD-10 Finland

Dental examination

0.8

67.4

6151

54874

KA3EB

NOMESCO Finland

Antegrade pyelography

6.9

67.3

119

128

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.4

67.3

270

594

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

67.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

67.3

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

67.3

8145/3-C16.2

ICD-O-3

Carcinoma, diffuse type of body of stomach

+∞

67.3

C18.12

ICD-10 Finland

Malignant tumor of the appendix carcinoma of the adenoma

+∞

67.3

JMA11

NOMESCO Finland

Laparoscopic total splenectomy

16.4

67.2

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

66.9

1375

6105

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

66.6

603

2031

P01AB01

ATC

metronidazole; oral, rectal

1.3

66.5

7519

45999

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

544.8

66.4

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

544.8

66.4

C18.69

ICD-10 Finland

Malignant tumor of colon descendens other or unspecified histology

+∞

66.4

C18.32

ICD-10 Finland

Malignant tumor of flexura hepatica carcinoma of adenoma

+∞

66.4

C18.59

ICD-10 Finland

Malignant tumor in flexura lienalis other or unspecified histology

+∞

66.4

A04AA03

ATC

tropisetron; systemic

38.3

65.9

ZX100

NOMESCO Finland

Oral

3.3

65.8

279

636

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

65.6

6337

56175

1CD02, ,

NOMESCO Finland

+∞

65.5

8144/3-C16.0

ICD-O-3

Adenocarcinoma, intestinal type of cardia, NOS

+∞

65.5

8140/3-C25.2

ICD-O-3

Adenocarcinoma, NOS, of tail of pancreas

+∞

65.5

DAB10

NOMESCO Finland

Partial excision of auricle

27.5

65.4

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

65.3

2823

14843

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.5

65.3

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.3

65.1

268

600

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

65.0

229

461

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

11.6

64.8

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

11.6

64.8

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

530.0

64.6

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

530.0

64.6

C18.81

ICD-10 Finland

Malignant overall tumor of the colon invasive carcinoma

+∞

64.6

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

64.6

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

64.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

64.6

C16

ICD-10 Finland

Malignant neoplasm of stomach

+∞

64.6

C187, 8148, 2

ICD-O-3

12.6

64.2

KAD00

NOMESCO Finland

Partial nephrectomy

10.3

64.2

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

4.2

64.0

191

340

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.7

63.9

367

998

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

9.4

63.9

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.9

63.8

321

812

JGB11

NOMESCO Finland

Laparoscopic partial proctectomy and end colostomy

+∞

63.6

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

83.2

63.5

XF612

NOMESCO Finland

Measurement of central venous pressure

8.1

63.5

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.0

63.4

R83

ICPC

Respiratory infection other

0.7

63.1

2017

21386

OAB48, ,

SPAT

0.5

62.9

792

10540

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

62.9

3322

32189

WPA16, ,

SPAT

25.3

62.7

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

62.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

62.7

R01AD12

ATC

fluticasone furoate; nasal

0.7

62.7

3225

31387

K75.0

ICD-10 Finland

Abscess of liver

6.6

62.0

113

126

SPAT1290

SPAT

Preparation of deceased person

11.8

61.9

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.7

61.8

3368

32492

8144/3-C16.9

ICD-O-3

Adenocarcinoma, intestinal type of stomach, NOS

+∞

61.8

8249/3-C17.9

ICD-O-3

Neuroendocrine tumor, grade 2 of small intestine, NOS

+∞

61.8

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

61.8

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

61.6

5528

32699

N02AA03

ATC

hydromorphone; systemic, rectal

8.4

61.6

OAA80, ,

SPAT

0.4

61.4

346

6109

ZZR10

NOMESCO Finland

Flap of skin and muscle

8.4

61.0

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.3

61.0

254

573

WZC00, ,

SPAT

0.6

61.0

1510

16900

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

500.4

60.9

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

60.9

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

60.9

PC2SC

NOMESCO Finland

Liver angiography with X-ray

174.4

60.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

60.7

665

9235

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

60.6

1339

6057

K03.64

ICD-10 Finland

Dental calculus supragingival

0.7

60.6

3503

33494

TJX90

NOMESCO Finland

Other minor procedure in gastroenterological surgery

8.2

60.5

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.4

60.4

455

1415

M05BX04

ATC

denosumab; parenteral

1.8

60.3

1047

4429

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.7

60.3

2986

29275

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

107.6

60.3

K31.5

ICD-10 Finland

Obstruction of duodenum

10.7

60.2

JN2BD

NOMESCO Finland

Extensive CT exmaniation of lower part of abdomen

7.9

60.1

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

5.2

60.1

137

193

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

492.9

60.0

L02BX03

ATC

abiraterone; oral

492.9

60.0

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

59.9

JFH10

NOMESCO Finland

Total colectomy and ileostomy

7.6

59.8

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

4.7

59.6

155

246

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.0

59.6

103

108

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

59.6

507

1664

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.0

59.5

290

720

ZXC40

NOMESCO Finland

Use of ultrasound

5.4

59.3

131

179

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

17.0

59.3

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

89.7

59.2

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

3.7

59.2

209

422

K85.8

ICD-10 Finland

Other acute pancreatitis

3.8

59.1

196

378

K62.7

ICD-10 Finland

Radiation proctitis

169.5

59.0

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

59.0

L08

ICPC

Shoulder symptom/complaint

0.7

58.9

2873

28256

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

58.9

806

3165

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

4.7

58.9

150

234

JFA73

NOMESCO Finland

Excision of lesion of small intestine

15.0

58.9

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

129.0

58.7

JFG30

NOMESCO Finland

Closure of colostomy with resection of exteriorised loop

12.4

58.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

58.6

2655

14062

TJF00

NOMESCO Finland

Insertion of jejunal tube

23.0

58.6

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

6.4

58.5

110

127

SDA02

NOMESCO Finland

Periodontal treatment, brief

0.8

58.3

4400

40497

TQW40

NOMESCO Finland

Remowal of suture of skin

1.7

58.3

1243

5570

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

58.3

301

773

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.3

58.2

455

1439

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

58.1

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

58.1

8070/3-C21.0

ICD-O-3

Squamous cell carcinoma, NOS, of anus, NOS

+∞

58.1

9680/3-C16.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of stomach, NOS

+∞

58.1

TJG20

NOMESCO Finland

Transanal irrigation

8.3

58.1

LEC00

NOMESCO Finland

Partial excision of vagina

20.9

57.8

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

57.7

3173

17387

JL2AT

NOMESCO Finland

Cytology of pancreas with ultrasound guidance

87.2

57.4

G04BE03

ATC

sildenafil; oral

4.2

57.3

168

295

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

470.7

57.3

FM1FN

NOMESCO Finland

Heart function isotope examination

470.7

57.3

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

57.2

SFA10

NOMESCO Finland

One-surface restoration

0.8

56.8

8014

68222

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

9.2

56.8

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.6

56.7

1070

12779

G47.3

ICD-10 Finland

Sleep apnoea

0.7

56.6

2955

28769

8480/3-C18.9

ICD-O-3

Mucinous adenocarcinoma of colon, NOS

+∞

56.2

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

56.2

C18.80

ICD-10 Finland

Malignant overall tumor of the colon without histology

+∞

56.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

56.2

R4110, ,

SPAT

0.6

56.2

1473

16305

L03

ICPC

Low back symptom/complaint

0.7

56.2

3601

33965

SPAT1254

SPAT

Administration of medicine

1.4

55.8

2861

15485

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.2

55.8

108

129

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

18.9

55.7

RD210, ,

NOMESCO Finland

2.8

55.6

306

814

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.2

55.6

513

1742

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

455.9

55.4

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019069) Monocytes/Leukocytes in Blood

11822

64616

1.70

317.15

6.3

6.0

9.25

9.00

11.92

11173

59943

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1987

5730

2.69

315.18

2.1

1.9

2.15

2.12

ug/l

0.04

1811

5019

(3006504) Eosinophils/Leukocytes in Blood

11785

64483

1.69

313.47

6.2

6.0

2.61

2.97

51.30

11140

59792

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

3000

8824

2.72

307.65

10.6

10.0

23.98

24.39

mmol/l

9.86

2970

8551

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5185

18827

2.32

307.65

5.4

5.9

1.00

1.04

mmol/l

11.14

4938

17337

(3014111) Lactate [Moles/volume] in Serum or Plasma

4233

13323

2.63

307.65

8.7

7.9

1.32

1.40

mmol/l

4.09

4165

13031

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9996

46134

2.04

307.65

5.6

2.8

43.95

34.59

u/l

10.23

9634

43042

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

6414

15229

3.89

307.65

4.5

2.2

16.89

7.56

umol/l

57.92

5922

13239

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3343

9830

2.75

307.65

10.5

10.1

1.25

1.36

10.23

3332

9759

(3032080) INR in Blood by Coagulation assay

15772

70794

2.98

307.65

15.3

17.3

1.24

1.32

inr

62.28

13235

59370

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

14920

60836

3.23

307.65

4.0

2.5

—

estimate

—

(3033658) Prothrombin time (PT) actual/Normal

9773

34345

2.88

307.65

6.9

3.8

84.56

87.27

21.25

9662

33519

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1873

1233

12.05

307.65

3.5

2.1

2138.26

10.03

u/ml

2.94

1859

1219

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

17294

71357

4.04

307.65

16.9

4.0

15.26

11.98

umol/l

45.71

16997

67072

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

13381

66158

2.14

307.65

8.8

6.1

1.19

1.21

mmol/l

111.86

12744

60232

(3027801) Oxygen [Partial pressure] in Arterial blood

5277

17775

2.53

307.65

9.1

7.9

13.84

11.62

kpa

140.37

5132

17065

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3176

9207

2.78

307.65

9.1

8.6

24.60

24.87

mmol/l

3.78

3162

9122

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

934

702

10.14

307.65

1.3

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

927

695

10.17

307.65

2.3

1.4

21.61

19.02

ug/l

0.85

912

673

(3002582) Erythrocytes [#/volume] in Urine

9536

48028

1.78

307.65

3.8

3.3

77.68

83.33

e6/l

0.13

7418

36556

(3022948) Iron [Moles/volume] in Serum or Plasma

7293

25254

2.63

307.65

2.6

2.7

10.99

12.86

umol/l

71.95

6998

23210

(3042936) Bacteria identified in Isolate by Culture

5295

20103

2.21

307.65

2.3

2.1

—

(3023368) Bacteria identified in Blood by Culture

10970

39948

2.92

307.65

5.6

4.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

15704

75427

2.63

307.65

17.7

6.7

4.19

4.29

e9/l

4.76

13821

63862

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3284

9445

2.81

307.65

10.6

10.5

0.62

0.64

2.46

3274

9388

(3021162) Amylase [Enzymatic activity/volume] in Specimen

386

101

28.54

307.65

3.0

2.3

969.94

3114.96

u/l

0.66

349

(40768797) Stomach Pathology biopsy report

4970

20594

1.98

307.65

1.6

1.2

—

(3000991) Gas panel - Venous blood

3993

12694

2.58

307.65

9.9

9.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

4190

13306

2.60

307.65

6.4

7.5

9.06

10.86

mmol/l

40.15

4035

12652

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6583

21691

2.72

307.65

2.4

2.8

19.12

22.45

61.94

6327

19907

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

351

103

25.41

307.65

3.1

1.1

55.46

22.96

u/ml

2.20

346

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3355

8303

3.30

307.65

9.9

10.6

15.64

16.13

18.63

3271

8033

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

15204

7527

40.90

307.65

7.8

1.5

39.36

6.54

ug/l

9.05

13812

5668

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

476

165

21.62

307.65

2.7

1.1

22.60

14.76

u/ml

5.77

458

147

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7094

22319

2.92

307.65

5.0

2.6

0.79

0.82

mmol/l

65.08

6842

20603

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7303

11551

6.31

307.65

3.2

2.1

0.20

0.21

g/l

12.74

7015

10523

(40768441) Liver Pathology biopsy report

1030

544

14.51

307.65

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

6307

2922

21.38

307.65

5.6

2.0

3526.13

90.34

u/ml

3.05

5732

2398

(3024561) Albumin [Mass/volume] in Serum or Plasma

16199

64121

3.82

307.65

10.5

4.0

32.96

35.73

g/l

307.65

15765

59174

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

5697

24899

1.90

307.65

2.0

1.9

—

(3003694) ABO and Rh group [Type] in Blood

7955

34730

2.04

307.65

1.4

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

7188

28556

2.23

307.65

7.5

2.2

2.48

2.45

mmol/l

103.97

6789

25046

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

14601

74261

2.19

307.65

9.7

6.5

1.19

1.21

mmol/l

144.21

12824

63698

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8919

38680

2.13

307.65

2.5

2.4

3.40

2.80

mg/l

59.77

7940

33152

(3002256) Pathology report gross observation

4658

11284

3.54

307.65

1.4

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

11989

41383

3.33

307.65

3.6

2.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4933

12731

3.34

307.65

3.9

2.4

61.80

46.28

u/l

0.48

4386

10647

(40768804) Tissue Pathology biopsy report

10861

44801

2.46

307.65

2.7

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3825

1698

19.61

307.65

5.2

2.1

1937.24

25.09

u/ml

8.74

3520

1523

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5277

17785

2.53

307.65

9.1

7.9

5.14

5.07

kpa

7.24

5136

17083

(3030467) Casts [#/volume] in Urine by Automated count

8509

41131

1.82

307.65

3.7

3.2

0.68

0.45

e6/l

5.96

6425

30037

(3018418) pH of Serum or Plasma

8849

43726

1.79

307.65

5.2

3.5

7.40

0.37

6308

31011

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6934

23503

2.66

307.65

2.4

2.7

2.35

2.31

g/l

5.97

6622

21453

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1861

719

20.59

307.65

5.6

1.7

13.98

4.19

nmol/l

1.67

1834

685

(3015377) Calcium [Moles/volume] in Serum or Plasma

10606

47063

2.20

307.65

7.7

2.2

2.34

2.35

mmol/l

23.23

10046

41398

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9698

31549

3.16

307.65

3.4

2.2

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

15973

86838

2.12

307.65

7.8

4.9

7.07

6.84

mmol/l

33.35

15585

82420

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

1189

544

16.87

307.65

6.3

1.3

213.78

82.23

nmol/l

7.21

1181

535

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2095

4470

3.69

307.65

2.6

3.2

0.31

0.35

iu/ml

4.51

1067

2575

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3524

10270

2.79

307.65

1.7

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4234

13852

2.52

307.65

3.8

2.3

251.17

235.78

u/l

3.52

4057

12838

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4732

14584

2.74

307.65

9.7

8.7

115.46

122.84

g/l

111.99

4640

14279

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2103

4523

3.66

307.65

1.5

1.4

191.58

281.94

ug/g

63.96

1333

2691

(3022145) Colonoscopy Study observation

6650

15670

3.97

307.65

1.6

1.3

—

(3003396) Base excess in Arterial blood by calculation

5228

17675

2.51

307.65

9.0

7.8

0.56

1.14

mmol/l

21.18

4550

14571

(3016502) Oxygen saturation in Arterial blood

4947

15926

2.63

307.65

9.3

8.2

96.61

95.03

56.42

4820

15386

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

11569

46778

2.62

307.65

4.0

2.4

71.53

61.40

u/l

0.89

11144

42920

(36304419) Bacteria [Presence] in Urine

7977

38520

1.79

307.65

3.6

3.1

0.31

72.94

estimate

0.63

212

(3019977) pH of Arterial blood

5309

17768

2.55

307.65

9.0

7.9

7.41

7.42

8.17

2472

10153

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18709

108949

2.33

307.65

19.1

6.0

114.60

76.42

u/l

307.65

18321

101823

(4035726) Immunohistochemistry procedure

5656

3835

13.99

307.65

1.5

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

11953

65949

1.68

304.76

6.3

6.0

23.48

27.31

228.89

11391

61945

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

265

25.24

301.90

3.5

2.2

88.68

62.01

pmol/l

1.10

228

(3022096) Basophils/Leukocytes in Blood

11752

64653

1.68

301.75

6.3

6.0

0.61

0.68

41.44

11101

59937

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

312

144

16.12

300.39

1.3

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1584

4157

2.93

298.30

3.3

1.5

95.44

23.83

u/ml

11.18

1541

3949

(3023183) Ammonium ion [Moles/volume] in Plasma

1365

3280

3.19

298.29

3.1

2.7

37.59

33.01

umol/l

6.73

1252

2938

(3037121) Protein [Mass/volume] in Urine

1697

4675

2.80

292.69

5.2

2.9

342.47

578.20

mg/l

1.15

1194

1761

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5172

22683

1.87

292.23

2.3

2.0

30.18

29.75

4.03

5069

22028

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5244

23163

1.86

289.36

3.5

3.0

2.72

2.75

e6/l

0.06

2662

11155

(40768795) Lymph node Pathology biopsy report

353

225

11.69

288.41

1.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

16696

139786

0.57

284.97

4.8

5.5

1.41

1.45

mmol/l

31.33

15013

129553

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

16849

140701

0.57

284.17

4.9

5.6

4.41

4.55

mmol/l

56.86

15298

131302

(4281824) Cell count and differential, peritoneal fluid

560

684

6.14

282.41

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

11675

64826

1.65

281.52

6.2

5.9

60.49

57.60

103.31

11213

61420

(3026782) Osmolality of Urine

5949

27707

1.78

273.61

3.3

2.9

527.91

531.32

mosm/kgh2o

0.57

5398

24048

(3027945) Reticulocytes/Erythrocytes in Blood

4129

17146

1.94

273.03

2.2

2.1

1.85

1.77

3.98

3729

14988

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1345

3381

3.04

272.26

2.5

3.53

3.60

g/l

0.81

1301

3221

(3018095) Leukocytes [#/volume] in Urine

10047

54029

1.64

271.22

4.5

3.9

125.89

114.92

e6/l

0.39

7547

37964

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

17332

143077

0.57

262.14

5.6

6.5

2.52

2.63

mmol/l

49.16

15621

133111

(3031040) Bacteria [#/volume] in Urine by Automated count

15421

93281

1.64

249.16

5.3

4.7

1909.48

1905.08

e6/l

0.00

240

1446

(3006315) Basophils [#/volume] in Blood

12412

71431

1.59

243.92

6.1

5.8

0.04

e9/l

22.63

10388

60617

(3001604) Monocytes [#/volume] in Blood

12370

71136

1.59

243.82

6.1

5.8

0.63

0.60

e9/l

19.22

10348

60396

(3019198) Lymphocytes [#/volume] in Blood

12572

72753

1.59

239.39

6.2

5.8

1.70

1.85

e9/l

8.64

10824

63251

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4291

18774

1.83

238.05

1.9

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6225

64676

0.60

236.74

2.0

1.39

1.35

mmol/l

3.22

5179

53417

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11135

63057

1.57

228.37

3.4

3.1

149.92

132.37

ug/l

5.82

10402

58134

(3013115) Eosinophils [#/volume] in Blood

12611

73546

1.57

226.80

6.4

5.9

0.18

0.20

e9/l

33.69

10749

63431

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

288

204

10.49

220.84

2.8

2.2

1246.50

14.11

ug/l

1.85

288

204

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5422

26005

1.69

216.23

3.4

2.8

1.25

1.12

e6/l

1.52

2858

14040

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3998

17606

1.81

214.71

1.9

1.8

—

(40758558) Short blood count panel - Blood

7848

41443

1.59

212.96

12.6

4.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

16123

133854

0.63

205.60

4.2

4.7

1.33

1.30

mmol/l

4.77

14382

122731

(3023487) Leukocytes [#/volume] in Peritoneal fluid

378

431

6.53

202.85

1.7

2.4

5824.45

2057.66

e6/l

0.66

258

299

(3023520) Reticulocytes [#/volume] in Blood

3169

13191

1.89

202.43

2.3

2.1

70.12

68.79

e9/l

1.04

2315

9813

(3000850) Epithelial cells [#/volume] in Urine

6492

33205

1.61

198.14

2.9

2.7

5.81

5.03

e6/l

4.28

6012

30116

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3649

16067

1.79

194.06

3.9

3.8

5.67

5.84

kpa

20.03

3565

15685

(3012544) pH of Venous blood

3689

16321

1.79

192.97

3.9

7.38

0.09

2173

9464

(3002032) Base excess in Venous blood by calculation

3567

15626

1.80

192.83

3.9

3.8

1.78

1.84

mmol/l

0.40

3049

13805

(40768800) Prostate Pathology biopsy report

488

758

4.81

191.90

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

828

1926

3.24

189.40

1.2

1.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1232

3591

2.61

188.72

2.4

2.2

83.17

91.20

21.18

1213

3441

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3047

12888

1.85

183.79

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1402

4459

2.39

178.80

1.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

16811

137360

0.64

178.79

7.5

7.2

41.18

40.09

mmol/mol

37.15

15481

128021

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1140

3342

2.58

172.35

2.4

2.5

227.20

194.20

22.58

1100

3135

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2479

10038

1.91

170.14

8.1

7.0

24.36

24.56

mmol/l

1.75

2377

9672

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

315

365

6.41

166.60

1.6

2.2

12465.79

13917.43

e6/l

0.07

169

183

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1253

3939

2.41

163.59

1.8

1.7

—

(3044007) Cell count panel - Peritoneal fluid

307

371

6.15

156.23

1.6

2.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1772

6572

2.06

155.23

6.7

4.9

0.87

0.29

1676

6244

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1885

7232

2.00

150.34

6.4

4.7

1.60

1.61

0.29

1788

6892

(3010370) Gastrin [Moles/volume] in Serum or Plasma

202

158

9.47

145.27

2.6

1.6

65.83

47.11

pmol/l

0.81

169

135

(3019060) Gas panel - Arterial blood

2311

9652

1.84

142.76

6.0

4.8

—

(1761868) Lipid panel - Serum or Plasma

5115

51288

0.66

140.00

3.3

3.5

—

(3045142) Bone marrow Pathology biopsy report

368

595

4.60

138.14

1.3

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2156

8905

1.86

137.69

3.9

4.0

24.04

24.25

mmol/l

2.00

2130

8772

(3004809) Band form neutrophils/Leukocytes in Blood

671

1673

3.00

136.57

2.8

2.3

2.27

1.26

6.96

610

1454

(3013005) Retinol [Moles/volume] in Serum or Plasma

306

428

5.31

134.82

1.9

1.5

1.85

2.02

umol/l

1.98

288

387

(3047181) Lactate [Moles/volume] in Blood

1300

4523

2.18

133.62

7.3

5.7

1.46

1.35

mmol/l

2.57

1155

4033

(3039000) Anion gap in Blood by calculation

987

3053

2.44

132.98

8.5

6.7

11.03

11.38

mmol/l

2.62

901

2777

(3018572) Chloride [Moles/volume] in Blood

987

3054

2.44

132.88

8.5

6.7

105.92

104.72

mmol/l

11.81

901

2778

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

17328

138867

0.68

129.68

5.5

5.7

6.24

6.05

mmol/l

55.18

15747

127239

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

731

1974

2.78

129.05

6.1

12.00

12.09

mg/l

0.20

670

1816

(3017143) Hepatitis C virus Ab [Presence] in Serum

2590

11560

1.73

127.09

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

759

2133

2.67

124.23

5.5

6.0

2032.52

967.72

iu/ml

0.42

123

322

(40768793) Breast Pathology biopsy report

406

775

3.90

123.79

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

2934

13660

1.66

122.85

3.5

3.2

4.48

4.49

kpa

0.12

2856

13303

(3036489) Thrombin time

1318

4780

2.09

121.63

2.2

1.9

21.52

21.31

0.48

1247

4207

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

696

1898

2.75

120.60

1.2

1.1

1.65

1.52

g/l

9.99

653

1719

(3007566) Smooth muscle Ab [Titer] in Serum

1132

3970

2.15

113.70

1.3

1.2

98.93

133.65

titre

0.79

359

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3036

14572

1.61

111.81

4.8

3.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

16358

131542

0.71

108.88

5.1

5.3

2.05

1.97

mu/l

7.56

14760

120835

(1617658) Protocol used for examination of sentinel lymph nodes

117

+∞

107.94

1.1

0.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2440

11190

1.67

107.22

4.9

3.2

1.22

1.23

mmol/l

3.95

2228

9329

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1682

6935

1.84

106.88

1.5

1.6

1.68

1.58

g/l

3.99

1459

5911

(3042111) Morphology [Interpretation] in Bone marrow Narrative

499

1210

3.07

106.37

1.5

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

1108

3957

2.11

106.14

1.3

1.2

516.67

1019.47

titre

2.36

132

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

296

515

4.26

101.76

1.9

1.4

27.09

28.98

umol/l

2.18

288

482

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

583

1622

2.68

97.18

2.5

2.8

2731.07

6799.12

u/ml

0.29

(3026692) Albumin [Mass/volume] in Peritoneal fluid

236

356

4.91

95.94

1.3

1.6

13.33

12.54

g/l

0.56

187

252

(3037467) Urinalysis macro (dipstick) panel - Urine

15076

98604

1.35

94.22

5.5

4.6

1.88

82.12

0.50

167

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

13344

109789

0.75

91.53

4.2

4.3

15.02

14.92

pmol/l

4.64

12015

99944

(3018405) Lactate [Moles/volume] in Arterial blood

1310

5240

1.89

91.06

4.6

4.2

1.43

1.41

mmol/l

0.12

1285

5130

(3003434) Protein [Mass/volume] in Pleural fluid

579

1667

2.59

90.24

1.4

1.5

31.96

48.56

g/l

0.42

529

1462

(3002331) Protein [Mass/volume] in Peritoneal fluid

201

281

5.29

88.70

1.2

1.6

33.39

44.59

g/l

0.21

149

213

(3017181) Myelocytes/Leukocytes in Blood

2507

12123

1.58

87.95

3.6

3.8

1.10

0.71

10.83

1104

2606

(3004119) Hemoglobin [Mass/volume] in Venous blood

2192

10272

1.63

87.54

3.3

120.43

130.95

g/l

76.48

2144

9994

(40768806) Pleura Pathology biopsy report

445

1132

2.93

87.41

1.5

—

(3021589) Normoblasts [#/volume] in Blood

10080

62597

1.32

86.82

18.9

10.4

0.00

e9/l

2.41

7989

50992

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1648

7267

1.72

82.72

1.3

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

521

1493

2.60

81.96

1.4

2218.64

3411.68

e6/l

0.72

367

1058

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2579

27250

0.66

81.91

1.3

40.97

41.03

iu/ml

0.01

823

8466

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2365

25389

0.65

81.00

1.3

15.79

13.41

u/ml

0.45

844

9595

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

833

2975

2.10

79.51

1.5

1.4

—

(3045788) Cell count panel - Pleural fluid

442

1199

2.74

77.30

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

469

1316

2.65

76.90

1.4

1.5

55457.86

58655.75

e6/l

0.08

279

746

(3002179) Metamyelocytes/Leukocytes in Blood

2361

11603

1.55

76.54

3.5

3.6

0.81

0.55

5.65

1027

2574

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

113

8.60

76.27

6.6

1.4

31.74

87.48

ug/l

1.29

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

10.68

75.60

1.8

1.2

18.99

14.10

pmol/l

0.81

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1864

8745

1.62

73.49

3.0

2.9

1.21

0.02

1854

8710

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

575

1838

2.33

71.78

1.4

158.83

74.63

pmol/l

4.92

566

1793

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8326

51260

1.30

71.69

3.1

3.3

1472.38

1487.40

ng/l

0.11

7388

44226

(3021440) Promyelocytes/Leukocytes in Blood

2361

11775

1.53

71.30

3.7

3.8

0.15

0.06

7.52

968

2269

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1836

8663

1.61

70.59

3.0

2.8

0.65

0.62

2.96

1828

8640

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1030

4134

1.87

70.53

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

896

11837

0.54

69.77

2.0

2.1

3.49

ratio

0.01

748

9535

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1283

5524

1.75

69.76

2.0

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

7501

45766

1.30

68.14

1.9

1.7

20.27

nmol/l

0.01

6633

38293

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

13817

91198

1.28

66.64

5.1

3.2

109.38

48.50

u/l

182.36

13136

84605

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1185

5092

1.75

64.78

1.9

1.8

—

(3025941) Bacteria identified in Stool by Culture

1519

7011

1.63

63.63

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

567

8403

0.48

63.20

1.7

1.8

3.35

3.44

mmol/l

1.09

417

6023

(3020891) Body temperature

1633

7689

1.60

63.08

5.1

4.6

36.87

36.91

°c

2.31

1623

7620

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

827

3202

1.93

63.05

1.5

1.4

—

(3025159) Blasts/Leukocytes in Blood

2337

11931

1.49

62.64

3.8

4.0

0.14

0.03

1.03

903

2173

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

211

413

3.78

62.34

2.8

2.4

0.60

0.61

mmol/l

1.34

211

413

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

189

341

4.10

62.22

3.3

2.3

1.59

0.99

3.10

189

341

(3005719) IgG [Mass/volume] in Serum or Plasma

1980

9800

1.53

61.45

2.6

2.4

10.79

10.82

g/l

0.12

1823

8985

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5294

31140

1.32

61.39

4.0

4.2

387.23

546.35

ng/l

1.46

4485

25609

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

832

3267

1.90

60.82

1.6

1.4

—

(3019225) pH of Specimen

2696

14273

1.44

59.74

4.6

3.8

7.37

7.35

2.67

2234

9506

(3012501) Base excess in Blood by calculation

771

2971

1.94

59.59

4.5

4.1

2.81

2.60

mmol/l

1.15

559

2019

(3013290) Carbon dioxide [Partial pressure] in Blood

771

2973

1.94

59.48

4.5

4.1

4.96

5.02

kpa

1.44

759

2890

(3027315) Oxygen [Partial pressure] in Blood

773

2995

1.93

58.80

4.5

4.2

8.94

8.43

kpa

7.67

761

2911

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

102

7.16

58.12

1.9

2.9

54.81

58.31

0.27

(21494755) Public health laboratory ask at order entry panel

694

9388

0.53

58.05

1.3

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

396

1179

2.49

57.71

2.6

2.3

61.13

60.75

0.13

341

992

(3027273) Bicarbonate [Moles/volume] in Venous blood

1581

7570

1.57

56.71

3.6

3.4

24.80

25.34

mmol/l

6.65

1528

7332

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

596

2135

2.08

56.39

1.6

1.4

—

(3010421) pH of Blood

1051

4538

1.74

56.38

4.1

3.7

7.41

1.66

1040

4463

(3036782) Glucose [Moles/volume] in Pleural fluid

383

1144

2.48

55.45

1.3

6.28

6.66

mmol/l

1.60

359

1051

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

372

1097

2.52

55.31

1.3

655.51

403.46

u/l

0.61

353

1020

(3000963) Hemoglobin [Mass/volume] in Blood

19701

150857

0.74

53.72

51.1

23.1

124.47

136.42

g/l

307.65

19505

148783

(3010813) Leukocytes [#/volume] in Blood

19702

150858

0.74

53.62

50.8

23.0

7.10

6.71

e9/l

74.35

19256

146313

(3026361) Erythrocytes [#/volume] in Blood

19700

150842

0.74

53.56

50.7

22.9

4.21

4.50

e12/l

307.65

19253

146298

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

19699

150834

0.74

53.53

52.2

23.4

37.66

40.86

220.80

19482

148675

(3024731) MCV [Entitic mean volume] in Red Blood Cells

19700

150835

0.74

53.43

50.6

22.9

91.28

91.47

6.19

19500

148732

(3035941) MCH [Entitic mass]

19699

150826

0.74

53.38

50.6

22.9

30.09

30.45

116.49

19495

148726

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

671

2566

1.95

53.02

1.5

—

(3007461) Platelets [#/volume] in Blood

19698

150797

0.74

52.95

50.8

23.0

250.16

244.62

e9/l

19.55

19327

146951

(3028026) IgM [Mass/volume] in Serum or Plasma

1582

7710

1.54

52.36

1.8

1.5

1.33

1.20

g/l

1.30

1459

7055

(3019309) Folate [Moles/volume] in Red Blood Cells

4810

28443

1.31

52.29

1.8

1172.93

1160.85

nmol/l

0.36

3696

21515

(3020630) Protein [Mass/volume] in Serum or Plasma

2375

12700

1.42

49.18

2.5

1.6

64.48

66.66

g/l

29.33

2166

11458

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

277

747

2.75

49.12

2.3

1.7

—

(3049717) Cytology report of Urine Cyto stain

1076

4864

1.66

48.65

2.8

1.8

—

(1616796) Gas panel - Central venous blood

781

3228

1.80

48.56

3.7

4.0

—

(3052851) Hemolysis interference index of Serum or Plasma

907

3941

1.72

47.50

4.3

3.4

2.16

1.68

index

1.77

543

1887

(3024928) Oxygen saturation in Venous blood

923

4031

1.71

47.46

2.8

3.2

60.40

61.85

1.05

897

3873

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9416

60900

1.23

46.48

4.3

4.0

44.59

76.82

ng/l

3.43

7753

44841

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

882

3829

1.72

46.33

4.4

2.9

1.71

1.70

mg/l

0.07

812

3378

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1034

4687

1.65

46.23

2.4

2.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

157

310

3.74

45.96

2.0

1.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

346

1085

2.36

45.19

2.8

2.4

—

(3000012) Reticulocyte production index

531

1979

1.99

45.16

2.0

1.7

0.87

0.90

0.47

412

1283

(40761536) Microorganisms panel - Urine sediment

1994

10546

1.43

43.64

4.6

4.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

463

1670

2.06

43.07

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

485

1780

2.02

43.05

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

494

1830

2.00

42.75

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

484

1781

2.02

42.66

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

463

1677

2.05

42.60

1.5

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

464

1683

2.05

42.53

1.5

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1647

8467

1.46

41.88

4.5

3.9

46.13

47.45

1.36

1628

8356

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2190

11868

1.39

41.60

4.2

2.4

65.52

63.31

ml/min/173m2

1.65

1031

4766

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

7.07

41.36

1.5

1.2

1839.33

148.69

u/l

0.96

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

205

523

2.90

40.30

2.1

2.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

281

849

2.45

39.84

1.3

13.66

12.68

u/l

0.26

253

765

(40760892) CBC W Ordered Manual Differential panel - Blood

4807

29313

1.26

39.11

4.7

4.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

961

4459

1.61

39.09

4.8

4.6

3.83

3.90

mmol/l

4.29

954

4422

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

6.27

38.85

1.7

3.1

24.47

16.11

0.83

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

435

1595

2.02

38.75

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

512

1989

1.91

38.68

1.1

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2231

12290

1.37

38.18

2.7

1.8

415.21

370.75

nmol/l

15.11

2108

11252

(3016650) Hepatitis A virus Ab [Presence] in Serum

500

1938

1.92

38.03

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

706

3060

1.72

37.30

2.6

2.7

15.13

16.68

28.58

699

2994

(3028626) Oxygen [Partial pressure] in Capillary blood

808

3658

1.65

36.26

3.7

3.2

8.07

8.01

kpa

0.38

789

3573

(3001893) Eosinophils/Leukocytes in Pleural fluid

146

324

3.33

36.15

1.4

2.45

2.90

0.23

121

266

(3006922) Hepatitis E virus Ab [Presence] in Serum

305

1001

2.26

36.01

1.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1904

10344

1.38

35.37

3.8

3.6

5.06

5.17

kpa

6.69

1807

9803

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

191

505

2.79

35.28

1.6

1.5

4.14

3.77

mg/l

0.56

183

481

(3005532) Lymphocytes/Leukocytes in Pleural fluid

160

383

3.08

35.13

1.3

1.4

58.19

63.40

0.93

132

302

(21494434) Karyotype in Bone marrow

230

673

2.53

34.93

1.2

1.1

—

(3009343) pH of Capillary blood

1849

10032

1.38

34.59

3.8

3.6

7.42

0.54

1555

8347

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

272

865

2.33

34.55

1.1

—

0.62

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

196

532

2.72

34.50

1.9

17.59

16.00

0.92

191

512

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

530

2162

1.82

34.45

1.4

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

338

1180

2.12

34.33

2.8

—

(1175426) CD3 cells/Lymphocytes in Blood

202

562

2.66

33.93

2.0

1.9

70.66

72.67

0.89

196

531

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

666

2920

1.70

33.76

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

666

2920

1.70

33.76

1.3

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

482

1925

1.86

33.52

1.3

1.5

159.11

154.44

au/ml

0.37

125

622

(3035880) pH of Pleural fluid

217

630

2.55

33.51

1.2

1.3

7.41

7.40

0.19

156

435

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

14706

114874

0.84

32.89

44.3

19.8

329.19

332.33

g/l

286.45

14608

114219

(40765096) Chromosome analysis panel by Banding

131

4.67

32.33

1.2

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

418

1615

1.92

32.16

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1626

8745

1.39

31.98

3.6

3.5

2.04

1.86

mmol/l

0.89

1170

6456

(3035933) Granulocytes/Leukocytes in Blood

590

2542

1.72

31.88

3.5

3.0

58.84

58.48

0.26

590

2542

(3044242) Glucose [Moles/volume] in Arterial blood

266

871

2.26

31.64

2.7

1.9

8.12

8.23

mmol/l

0.16

266

871

(3011412) CD3 cells [#/volume] in Blood

241

757

2.35

31.52

2.2

2.1

1108.31

1124.92

e6/l

0.09

223

671

(3020564) Creatinine [Moles/volume] in Serum or Plasma

19671

149304

0.79

31.44

44.2

20.1

80.48

80.30

umol/l

0.26

19458

147198

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

218

3546

0.45

31.30

1.2

1.53

1.51

g/l

0.51

218

3546

(3028271) Lactate [Moles/volume] in Capillary blood

536

2273

1.75

30.63

1.9

1.78

1.74

mmol/l

0.41

529

2213

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

191

3239

0.43

30.58

1.1

0.64

0.63

ratio

0.27

540

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

663

2989

1.65

30.27

1.4

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

127

292

3.21

29.85

1.4

26.65

21.27

1.08

111

262

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

355

1341

1.96

29.22

1.4

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

272

931

2.16

29.11

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

494

2079

1.76

29.00

1.4

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

123

284

3.19

28.73

1.2

1.3

495.21

9.72

ug/l

1.39

131

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

28.58

1.1

0.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

254

854

2.20

28.42

1.4

13.42

13.46

u/l

0.03

248

819

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

7.36

28.37

1.4

1.0

2.59

1.49

ug/l

0.96

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10611

71382

1.17

28.19

2.4

2.2

89.61

95.99

pmol/l

35.77

6403

37125

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

16.41

28.16

1.1

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

333

1248

1.97

28.05

1.2

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

844

4108

1.53

27.89

3.8

3.2

1.68

1.62

mmol/l

0.85

831

4012

(46235355) HIV 1 and 2 tests - Meaningful Use set

2595

15241

1.28

27.81

1.5

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

265

919

2.13

27.48

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

738

3502

1.57

27.32

1.2

1.3

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

257

883

2.15

27.29

1.5

1.6

—

(3021901) Oxygen saturation in Capillary blood

689

3219

1.59

27.26

3.0

3.1

89.32

89.60

0.43

673

3133

(3038515) Glucose [Moles/volume] in Venous blood

727

3451

1.57

26.88

3.9

3.3

7.74

7.77

mmol/l

0.09

716

3368

(3051611) Lipemic interference index of Serum or Plasma

363

1423

1.89

26.82

4.7

3.5

13.12

12.79

index

0.17

254

654

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

592

6834

0.63

26.58

1.6

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

571

2565

1.65

26.48

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

565

2534

1.65

26.36

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2337

13633

1.29

26.34

3.0

3.2

210.21

224.62

ng/l

0.83

2145

12524

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

282

1020

2.04

26.23

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

155

431

2.65

26.19

2.8

2.6

34.87

43.21

5.99

214

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1562

15042

0.75

25.79

1.5

—

6.20

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

863

9156

0.68

25.69

1.2

1.3

52.41

55.08

au/ml

0.14

623

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

961

9996

0.69

25.67

2.3

2.5

26.04

23.65

au/ml

0.24

936

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

198

630

2.32

25.27

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

198

630

2.32

25.27

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

536

6255

0.62

25.23

1.6

1.7

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

542

2434

1.65

25.18

1.7

1.6

0.89

0.86

g/l

0.14

410

1902

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2205

12852

1.29

24.95

2.8

2.3

0.61

0.45

e6/l

2.45

2151

12286

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

749

3659

1.52

24.36

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

754

3691

1.52

24.29

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

753

3702

1.51

23.77

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

217

743

2.16

23.32

1.5

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

19455

138256

1.21

23.05

33.7

15.2

37.40

24.53

mg/l

307.65

18564

112968

(3024471) HLA-A [Type]

134

371

2.66

22.90

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

574

2680

1.59

22.83

1.1

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

774

3876

1.48

22.37

5.0

4.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

19477

147247

0.83

22.29

23.5

11.0

28.85

26.12

u/l

34.64

19160

141908

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.76

22.05

1.5

—

(3003181) Sodium [Moles/volume] in Urine

637

3071

1.54

22.04

1.4

56.79

61.68

mmol/l

2.14

457

2463

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1693

15798

0.77

21.97

1.4

—

(3024932) HLA-DR beta [Type]

131

367

2.63

21.90

1.1

1.0

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

207

714

2.14

21.88

1.5

1.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

125

342

2.69

21.87

1.3

3.48

3.27

mmol/l

0.25

112

308

(3017569) Oxygen content in Arterial blood

248

918

2.00

21.75

3.0

2.1

14.66

16.17

9.89

248

918

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.97

21.72

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

8.09

21.45

1.7

1.0

79.58

25.12

umol/24h

0.65

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

292

1151

1.88

21.33

1.7

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

376

1605

1.73

21.15

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

376

1606

1.73

21.10

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

376

1606

1.73

21.10

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

376

1606

1.73

21.10

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

861

8824

0.71

21.04

1.3

253.05

243.20

u/ml

0.10

782

8230

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

4.62

20.94

2.3

4.5

1.47

1.45

mg/l

0.02

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

226

821

2.03

20.89

1.4

—

(3012516) Albumin [Mass/volume] in Urine

7088

57410

0.87

20.50

3.5

59.40

44.72

mg/l

4.93

4857

36568

(3037756) Immunofixation for Serum or Plasma

606

2941

1.53

20.37

1.5

1.2

—

(3042631) Mycobacterium sp identified in Specimen

398

1746

1.69

20.30

2.3

3.0

—

(3045716) Anion gap in Serum or Plasma by calculation

402

1774

1.68

20.06

3.5

2.9

11.54

10.66

mmol/l

3.52

395

1755

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

10.82

19.66

1.1

1.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

338

1430

1.75

19.65

1.2

69.07

56.46

u/l

1.35

308

1226

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

438

1988

1.63

19.62

1.3

307.01

280.63

u/ml

0.91

277

1260

(3008898) HLA-B27 [Presence]

310

3887

0.58

19.60

1.1

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

163

3.39

19.39

1.4

11.38

10.58

0.10

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

302

1241

1.80

19.38

1.7

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

362

4340

0.61

19.15

1.4

1.8

6.14

4.60

mg/l

1.10

303

3255

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

166

558

2.19

18.78

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

166

558

2.19

18.78

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

410

4751

0.63

18.75

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

124

368

2.48

18.55

2.5

1.9

25361.84

34177.43

u/ml

0.10

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

158

3.36

18.37

1.3

48.36

252.90

u/l

0.46

101

(3026051) Granulocytes/Leukocytes in Pleural fluid

245

2.83

18.08

1.3

1.4

24.32

26.81

0.31

197

(3022475) Manganese [Moles/volume] in Blood

5.67

17.84

1.4

1.1

0.16

umol/l

0.01

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

240

944

1.88

17.74

2.4

2.3

30.95

29.24

iu/ml

0.07

115

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

169

587

2.12

17.66

1.8

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

169

587

2.12

17.66

1.8

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

169

587

2.12

17.66

1.8

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

169

589

2.12

17.51

1.8

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

152

510

2.20

17.31

32.5

30.8

119.78

112.86

ug/l

0.65

124

408

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1090

6065

1.34

17.18

2.2

2.3

459.31

630.69

ug/l

0.97

1054

5762

(3009508) Creatinine [Moles/volume] in Urine

7333

58769

0.88

17.18

3.5

7.20

7.49

mmol/l

7.45

6088

49527

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

208

2.94

17.13

2.3

1.3

22.91

24.10

u/l

0.05

184

(3022313) Gas panel - Capillary blood

1252

7111

1.31

17.09

4.1

3.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

567

2828

1.49

16.81

1.3

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

132

423

2.30

16.77

5.9

1.2

33.03

265.38

u/ml

4.36

100

(3001019) Free T4 and TSH panel - Serum or Plasma

429

4801

0.65

16.74

1.6

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

126

398

2.33

16.54

2.0

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

201

764

1.94

16.49

1.3

1.2

82.64

84.17

0.11

(3019832) Treponema pallidum Ab [Presence] in Serum

534

5689

0.68

16.24

1.5

1.6

—

(3017732) Neutrophils [#/volume] in Blood

2860

17921

1.20

16.24

4.8

2.8

4.88

4.56

e9/l

1.05

2487

15101

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

259

1074

1.78

16.22

1.6

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

259

1074

1.78

16.22

1.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

259

1074

1.78

16.22

1.6

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4017

25922

1.17

16.07

1.5

1.4

2.84

2.62

g/l

5.93

2430

15075

(3015171) Extractable nuclear Ab [Units/volume] in Serum

545

5770

0.69

16.02

1.2

1.60

0.68

u/ml

0.67

473

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

123

391

2.32

15.94

2.0

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

123

392

2.31

15.85

2.0

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

148

513

2.13

15.61

1.4

1.3

1717751.50

1999938.50

iu/ml

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

644

3341

1.43

15.58

1.5

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1005

5607

1.33

15.57

3.1

2.9

24.49

24.89

mmol/l

1.95

987

5511

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

131

3.37

15.49

1.3

1.4

71.98

65.95

0.65

107

(3006184) Hemoglobin [Mass/volume] in Capillary blood

725

3850

1.40

15.37

2.3

2.2

120.51

131.46

g/l

24.01

565

2947

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4796

31469

1.15

15.24

1.9

1.7

2.26

1.20

mg/l

30.65

3990

24610

(3000494) Fungus identified in Specimen by Culture

2821

17753

1.19

15.20

1.6

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.66

14.96

1.6

1.1

—

(3000330) Specific gravity of Urine by Test strip

1372

8024

1.27

14.95

4.7

3.4

1.02

ratio

1.61

1252

7270

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

160

588

2.01

14.51

2.3

2.1

0.61

0.73

e9/l

0.84

154

556

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

976

5479

1.32

14.50

4.1

3.8

24.75

24.88

mmol/l

0.56

879

4975

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

229

2863

0.58

14.43

1.3

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

180

2.90

14.43

1.3

1.1

60.18

66.16

ug/l

1.96

180

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

203

811

1.85

14.41

1.6

1.5

5.95

7.48

u/l

0.76

159

644

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5116

33834

1.14

14.38

1.8

17992383.74

34211526.28

pmol/l

1.54

4213

27836

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

185

2.87

14.30

1.4

1.2

16225.71

985.29

u/ml

—

(3009261) Glucose [Presence] in Urine by Test strip

11404

79218

1.11

13.79

4.6

4.0

0.79

0.23

estimate

0.49

2594

14733

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

836

4636

1.34

13.54

2.6

1.5

2.70

1.55

ratio

1.68

482

2637

(3048689) Calprotectin [Mass/mass] in Stool

2714

17188

1.18

13.50

2.0

2.3

229.00

141.06

ug/g

19.45

2209

13533

(3021601) Nitrite [Presence] in Urine by Test strip

11191

77711

1.11

13.49

4.5

4.0

0.00

estimate

0.21

2662

15397

(3000093) Morphology [Interpretation] in Blood Narrative

271

1202

1.66

13.45

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

108

3.41

13.17

1.4

1.0

—

(3042733) HLA Ab [Presence] in Serum

133

475

2.06

13.08

2.3

5.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

120

3.25

13.01

2.8

1.2

63.68

100.95

ng/l

1.52

(3042010) Triglyceride [Moles/volume] in Pleural fluid

200

2.69

12.94

1.3

1.2

2.20

0.81

mmol/l

0.75

115

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

622

3320

1.39

12.86

1.4

1.7

0.81

0.84

nmol/l

0.66

545

2768

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

202

836

1.78

12.85

1.2

168.73

87.27

u/l

2.84

175

708

(3022493) Free Hemoglobin [Mass/volume] in Plasma

164

638

1.90

12.70

2.1

5.5

63.86

1341.41

mg/l

1.33

128

441

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

165

2171

0.56

12.63

1.1

2.47

1.40

u/ml

0.49

1181

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1429

0.46

12.63

1.0

38.45

43.58

ng/l

0.47

988

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1426

0.46

12.56

1.0

712.48

721.53

ng/l

0.07

963

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

442

4640

0.69

12.47

1.7

1.9

45.77

43.21

nmol/l

1.03

421

4504

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1421

0.46

12.44

1.0

302.78

334.91

ng/l

0.48

997

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

196

812

1.78

12.44

1.2

45.60

22.50

u/l

2.82

168

672

(3023420) DNA double strand Ab [Units/volume] in Serum

634

6258

0.74

12.27

1.7

7.08

7.13

iu/ml

0.02

151

1501

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

348

1678

1.53

12.25

1.3

1.35

1.44

nmol/l

0.64

310

1533

(4034850) Laboratory test

502

5135

0.71

12.19

13.7

10.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

150

575

1.92

12.16

2.1

3.3

17.46

26.14

mu/l

3.21

140

539

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

269

1224

1.62

12.14

1.2

50.00

121.47

titre

—

(3035350) Ketones [Presence] in Urine by Test strip

11309

78829

1.11

12.10

4.6

4.0

7.80

4.00

estimate

1.12

2754

15869

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

269

1226

1.62

12.06

1.2

118.78

190.64

titre

1.14

202

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

253

2947

0.63

11.99

1.8

1.9

—

(3026250) Tacrolimus [Mass/volume] in Blood

146

560

1.92

11.83

42.3

41.0

6.61

7.29

ug/l

5.00

130

510

(3027923) C peptide [Moles/volume] in Serum or Plasma

219

952

1.70

11.78

1.4

1.08

1.27

nmol/l

2.49

171

687

(3020682) Albumin/Creatinine [Ratio] in Urine

7401

58379

0.90

11.77

4.3

4.2

10.99

7.87

mg/mmol

4.77

4845

36327

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.90

11.71

4.0

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

440

4565

0.70

11.63

1.2

1.3

30.75

44.76

u/ml

0.41

235

(3017315) Amylase [Enzymatic activity/volume] in Urine

189

791

1.76

11.63

1.3

1.2

305.08

368.11

u/l

0.35

176

729

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

249

1125

1.63

11.58

1.1

1.0

294.78

285.66

mg/l

1.02

231

1024

(3020717) Zinc [Moles/volume] in Serum or Plasma

169

685

1.82

11.57

1.7

1.4

29.08

20.98

umol/l

2.13

150

630

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

204

2477

0.60

11.55

1.7

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

225

992

1.67

11.50

1.0

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

919

5288

1.29

11.44

2.7

1.5

51.54

36.33

mg/l

0.64

785

4449

(3020876) Protein [Mass/time] in 24 hour Urine

356

1760

1.49

11.19

2.3

2.1

1.17

1.33

g/24h

0.57

233

978

(3034860) Kappa light chains.free [Mass/volume] in Serum

918

5307

1.28

11.03

2.7

1.5

61.25

45.95

mg/l

1.54

784

4474

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

293

3240

0.66

10.93

1.2

43.48

51.25

u/ml

0.35

304

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

274

1287

1.57

10.89

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1897

11871

1.19

10.78

3.8

4.0

91.88

93.75

ng/l

0.40

1653

10097

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

143

565

1.87

10.65

2.4

2.0

258.46

232.07

e6/l

0.47

127

490

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1092

6478

1.25

10.59

2.1

1.4

3.78

3.76

g/l

0.26

985

5819

(3008401) Mugwort IgE Ab [Units/volume] in Serum

135

1783

0.55

10.56

1.1

1.23

1.07

u/ml

0.16

737

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1416

12453

0.82

10.51

1.4

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

347

3684

0.69

10.49

1.8

1.9

199.26

203.81

pmol/l

0.38

331

3483

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

102

3.17

10.48

1.2

1.4

1.41

1.04

ml/s/173m2

0.87

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1092

6492

1.25

10.39

2.1

1.4

4.20

4.23

g/l

0.65

987

5837

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1093

6502

1.25

10.35

2.1

1.4

7.57

7.48

g/l

0.93

986

5838

(3000475) Leukocytes [#/volume] in Synovial fluid

452

4574

0.72

10.33

1.6

14832.05

14466.75

e6/l

0.07

313

3270

(3015736) pH of Urine

9032

62585

1.10

10.26

4.0

3.6

6.22

6.23

0.36

4842

34198

(40758358) Immune stain study

+∞

10.14

1.0

0.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

+∞

10.14

1.0

0.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

143

1834

0.57

10.09

1.1

5.09

3.08

u/ml

0.66

889

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6511

51390

0.90

10.04

2.2

2.3

225.12

226.56

u/l

0.03

6156

48319

(40761511) CBC panel - Blood by Automated count

18931

142028

0.89

10.00

29.3

13.9

—

6.27

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

301

2.15

9.79

1.3

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1027

6120

1.24

9.59

2.2

1.4

3.05

2.89

g/l

5.33

920

5457

(3041918) Cholesterol [Moles/volume] in Pleural fluid

256

2.24

9.59

1.2

1.44

1.45

mmol/l

0.03

133

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

354

1808

1.45

9.51

1.4

1.2

0.20

0.19

nmol/l

0.07

275

1472

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

423

4265

0.72

9.49

1.2

1.3

6.04

6.71

u/ml

0.09

646

(3009466) Valproate [Moles/volume] in Serum or Plasma

193

2258

0.62

9.43

4.2

5.0

333.45

352.35

umol/l

1.03

167

1947

(3044889) 12 lead EKG panel

14568

103397

1.09

9.38

4.9

4.3

0.50

2882.23

1.18

265

(3040151) Glucose [Moles/volume] in Capillary blood

355

1821

1.44

9.33

7.3

11.4

7.57

7.60

mmol/l

0.04

305

1501

(3052592) Norovirus Ag [Presence] in Stool

255

2.22

9.29

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

229

1074

1.57

9.25

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

188

841

1.65

9.20

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

948

5627

1.25

9.19

2.1

1.4

10.22

10.12

g/l

0.29

832

4925

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

426

4266

0.73

9.16

1.2

1.3

9.02

5.82

u/ml

0.31

407

(3004451) EKG impression Narrative

202

932

1.60

8.77

1.2

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

251

1221

1.52

8.64

1.9

1.7

1297.40

3504.77

u/l

1.09

448

(3006245) CD3-CD19+ cells/cells in Blood

273

2.13

8.62

2.1

1.9

12.58

8.95

1.25

250

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

121

2.74

8.40

1.1

1.2

0.04

0.44

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

135

567

1.75

8.36

2.3

1.9

519.71

453.28

e6/l

0.82

113

465

(3014133) Dog dander IgE Ab [Units/volume] in Serum

110

1435

0.56

8.35

1.1

3.70

3.05

u/ml

0.22

707

(3010726) Horse dander IgE Ab [Units/volume] in Serum

129

1603

0.59

8.17

1.1

1.59

1.06

u/ml

0.36

786

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

790

4663

1.25

8.09

2.3

1.5

0.02

0.01

g/l

0.69

705

4215

(3028300) Cannabinoids [Presence] in Urine

233

2529

0.67

8.04

1.5

1.9

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

18045

135396

0.91

8.01

34.6

14.7

77.49

76.81

ml/min/173m2

4.50

17220

124951

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

386

2068

1.38

7.99

1.4

1.3

0.74

2.34

nmol/l

0.90

369

1992

(3027008) Opiates [Presence] in Urine

233

2521

0.68

7.91

1.5

1.8

—

(3000060) B lymphocytes [#/volume] in Blood

188

2.31

7.84

1.9

1.8

1.52

0.15

e9/l

0.83

105

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

917

5524

1.23

7.81

2.2

1.5

0.74

0.35

g/l

3.47

784

4727

(3000764) Benzodiazepines [Presence] in Urine

233

2511

0.68

7.76

1.4

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

273

1383

1.46

7.76

2.0

1.3

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

165

748

1.63

7.75

1.1

97.68

81.51

u/l

1.54

158

641

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

347

3485

0.73

7.68

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

891

5365

1.23

7.63

1.3

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

154

2.44

7.63

1.2

1.1

—

(3016879) Cocaine [Presence] in Urine

217

2358

0.67

7.56

1.5

2.0

—

(44813793) Dust mix specific IgE antibody measurement

993

0.50

7.56

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

391

2122

1.36

7.50

1.4

1.3

0.38

0.24

nmol/l

0.29

149

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

163

745

1.61

7.43

1.1

35.71

21.49

u/l

2.28

153

636

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

530

1.72

7.29

2.9

2.7

4.75

5.06

kpa

2.90

124

530

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

124

530

1.72

7.29

2.9

2.7

10.00

10.22

kpa

0.42

124

530

(3037522) Nuclear Ab [Titer] in Serum

2468

20229

0.88

7.28

1.4

464.54

539.64

titre

1.30

533

4582

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

3.23

7.20

2.0

1.1

2.08

1.40

pmol/l

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.48

7.19

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1223

0.56

7.14

1.1

1.0

0.37

0.41

u/ml

0.06

417

(3027944) Amphetamines [Presence] in Urine

233

2470

0.69

7.14

1.5

1.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

751

4491

1.24

6.90

2.2

1.5

0.00

g/l

0.60

657

3948

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

914

8032

0.83

6.79

1.2

142.81

132.31

u/ml

0.29

276

3058

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

414

3976

0.76

6.78

1.2

1.3

1.59

19.03

u/ml

—

(3008536) Aspergillus sp Ab [Presence] in Serum

196

2.18

6.78

2.2

1.3

—

(40763590) HLA-DQ beta [Type]

16.17

6.75

1.0

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

178

1962

0.66

6.73

1.5

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

708

4227

1.24

6.62

2.3

1.5

0.00

g/l

-0.00

655

3938

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1080

0.56

6.55

1.2

1.4

146.46

177.44

pmol/l

1.60

1080

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

161

760

1.56

6.48

1.7

1.9

2.23

2.85

u/field

0.51

126

514

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

181

2.20

6.46

1.3

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

6382

44230

1.08

6.41

4.8

4.2

0.00

estimate

3.59

2306

14064

(3019150) Specific gravity of Urine by Refractometry

4544

35852

0.91

6.40

4.6

4.3

1.02

1.10

kg/l

0.81

3262

23451

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

384

3691

0.76

6.36

1.2

2.90

6.26

u/ml

1.08

245

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

360

1.82

6.36

1.1

—

(40760409) HLA-A [Type] by High resolution

13.48

6.35

1.0

1.2

—

(46236302) HLA-C [Type] by High resolution typing

13.48

6.35

1.0

1.2

—

(40760410) HLA-B [Type] by High resolution

13.48

6.35

1.0

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

119

526

1.67

6.26

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

113

1351

0.61

6.24

1.0

1.1

2.65

3.37

u/ml

0.36

584

(3014271) Vancomycin [Susceptibility]

171

827

1.52

6.20

2.8

3.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2246

14816

1.13

6.19

2.3

2.5

5.58

7.91

ug/l

8.86

1916

12985

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

2.78

6.05

1.0

1.2

38.33

42.55

mg/l

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2369

19256

0.89

6.03

4.7

5.5

32.81

32.62

0.34

1509

12716

(3037692) Legionella sp identified in Specimen by Organism specific culture

405

1.74

5.99

1.4

—

(3013862) HLA-DP [Type]

11.55

5.99

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

324

3158

0.75

5.97

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

327

1795

1.34

5.93

1.4

1.3

—

nmol/l

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

388

3687

0.77

5.93

1.3

582.10

559.76

mg/l

0.29

379

3511

(3011397) Hemoglobin [Presence] in Urine by Test strip

5383

37173

1.08

5.83

3.8

3.9

0.19

0.18

0.03

426

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

333

1.81

5.82

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

241

1265

1.40

5.77

2.0

1.89

3.75

u/field

0.48

148

678

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

536

4877

0.80

5.69

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

288

1.87

5.68

1.5

1.6

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

12.25

5.61

1.1

1.0

43.20

20.17

umol/l

—

(3008295) Osmolality of Serum or Plasma

288

1567

1.35

5.57

1.2

1.4

275.09

276.41

mosm/kgh2o

0.43

218

1163

(40758292) HTLV I+II Ab panel - Serum

117

2.39

5.55

1.5

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

117

2.39

5.55

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.69

5.55

1.9

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

150

724

1.53

5.54

2.6

1.6

37.44

8.84

umol/l

3.68

121

527

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.73

5.52

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

204

2.02

5.49

2.2

1.2

7.37

336.11

pmol/l

0.58

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

349

3319

0.77

5.40

1.1

3.11

3.35

0.16

361

(3014051) Protein [Presence] in Urine by Test strip

5829

40509

1.08

5.28

3.5

3.0

0.12

0.07

0.78

157

1220

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

187

956

1.44

5.23

1.4

1.5

12.66

13.77

umol/l

1.26

174

891

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

292

1.81

5.18

2.2

1.1

2.03

2.47

ug/l

0.43

208

(3008116) Ketones [Moles/volume] in Urine by Test strip

347

1.74

5.13

1.3

1.4

0.21

0.28

mmol/l

0.57

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.09

5.09

1.1

1.0

—

(3048879) Bone marrow aspiration report

257

1.86

5.07

1.5

1.2

2.00

—

(40757494) Bilirubin.total [Moles/volume] in Blood

160

800

1.47

5.04

2.5

2.0

90.45

18.48

umol/l

1.46

(3047189) Immunofixation for 24 hour Urine

105

479

1.61

4.98

1.5

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.42

4.96

6.9

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

533

3192

1.23

4.96

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.25

4.83

1.2

1.0

1.07

0.86

u/field

1.00

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

134

653

1.51

4.80

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

272

1504

1.33

4.79

1.4

1.5

0.44

0.43

g/l

0.17

183

1109

(3041096) Erythrocytes [Presence] in Urine by Automated

5744

40019

1.07

4.79

4.4

3.5

0.30

0.28

estimate

0.03

2135

12003

(3028192) IgG subclass 2 [Mass/volume] in Serum

272

1505

1.33

4.77

1.4

1.5

3.04

3.01

g/l

0.09

183

1105

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

347

3243

0.78

4.73

1.4

1700.92

1512.68

e6/l

0.07

271

2615

(3027456) Digoxin [Moles/volume] in Serum or Plasma

610

3723

1.21

4.73

3.2

3.3

0.84

0.81

nmol/l

0.66

495

3030

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

957

0.61

4.73

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

342

3199

0.78

4.70

1.3

1.4

13.34

26.48

e6/l

1.74

250

2422

(3032057) Clostridioides difficile [Presence] in Stool

303

1.75

4.63

1.8

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

271

1506

1.33

4.63

1.4

1.5

6.86

6.85

g/l

0.02

182

1103

(3014891) Appearance of Pleural fluid

187

1.97

4.62

1.5

1.4

—

(3030703) Everolimus [Mass/volume] in Blood

+∞

4.61

14.6

0.0

4.68

—

ug/l

—

(4062490) Immunoglobulin typing, IgG

265

1471

1.33

4.57

1.4

1.5

—

(3013512) EKG study

7923

55860

1.06

4.57

4.3

3.8

0.72

0.01

160

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

350

3249

0.79

4.53

1.2

3.89

3.86

mmol/l

0.22

336

3085

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

264

1469

1.32

4.49

3.7

3.8

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

527

0.49

4.46

2.6

2.7

154.11

148.90

nmol/l

0.12

466

(3002619) Bacteria identified in Specimen by Culture

374

1.65

4.43

1.2

1.3

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

208

1119

1.37

4.42

1.2

10.72

9.41

mmol/l

3.18

185

1051

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.79

4.39

5.5

1.4

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

220

2160

0.75

4.39

1.6

1.5

60.51

59.27

0.17

136

1371

(3003329) Lymphocytes/Leukocytes in Synovial fluid

159

1641

0.71

4.37

1.5

28.15

28.62

0.06

1023

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

156

2.03

4.34

1.3

71.92

112.45

ug/l

1.02

(44786800) Granulocytes/Leukocytes in Body fluid

132

2.12

4.29

1.3

34.84

28.25

0.46

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

112

1216

0.68

4.11

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

19618

145826

0.93

4.04

40.2

19.0

3.96

3.99

mmol/l

50.89

19367

142495

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

179

1787

0.73

4.03

1.1

2.99

2.96

0.01

226

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

157

1595

0.72

3.96

1.2

7.90

7.59

mmol/l

0.59

140

1349

(3016038) Potassium [Moles/volume] in Urine

206

1131

1.34

3.90

1.3

1.2

35.38

33.26

mmol/l

0.67

188

952

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

140

721

1.43

3.88

1.9

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

138

1424

0.71

3.84

1.1

—

30.04

—

(3004616) Nuclear Ab [Presence] in Serum

206

1997

0.76

3.82

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

833

5329

1.15

3.77

1.6

29.26

22.68

u/ml

0.97

178

1101

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

515

4500

0.84

3.76

1.5

0.40

6.67

iu/ml

0.93

123

874

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

204

1974

0.76

3.74

1.1

15.14

18.60

au/ml

0.29

389

(3003327) Ova and parasites identified in Stool by Light microscopy

736

4670

1.16

3.73

1.6

1.7

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

164

1637

0.73

3.73

2.1

2.2

1.50

10.10

titre

—

(3001186) Copper [Moles/volume] in Serum or Plasma

347

1.61

3.70

1.2

16.93

16.25

umol/l

0.74

309

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

131

673

1.43

3.70

1.1

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.15

3.68

3.5

1.1

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

3.98

3.65

1.2

1.00

0.69

u/field

—

(3021788) Differential panel - Synovial fluid

370

3323

0.82

3.63

1.5

—

0.94

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

912

0.65

3.61

1.2

1.1

47.16

43.68

mg/l

0.29

783

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

174

1.86

3.55

1.8

1.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

108

2.11

3.53

1.8

1.6

1.33

1.39

umol/l

0.27

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

870

0.65

3.51

1.1

11.02

8.70

iu/ml

0.25

191

(3028707) Methadone [Presence] in Urine by Screen method

109

1150

0.70

3.49

1.7

2.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

116

590

1.45

3.48

1.6

1.7

5.42

7.70

nmol/l

0.23

487

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2429

19187

0.92

3.42

11.8

7.0

—

(3006270) Folate [Moles/volume] in Blood

221

1252

1.30

3.41

1.3

1.2

340.68

347.28

nmol/l

0.17

175

1018

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

145

1.93

3.41

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

100

1065

0.69

3.39

1.2

1.3

1.13

1.20

u/ml

0.04

643

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1356

0.72

3.37

1.1

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

176

1706

0.76

3.32

1.4

82708.01

140372.12

e6/l

0.78

116

1154

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

121

627

1.42

3.31

2.9

1.6

209.90

200.70

u/l

0.39

121

620

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

135

1360

0.73

3.31

1.1

—

49.97

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

641

0.61

3.28

1.1

3.09

6.40

u/ml

—

103

(3012565) Volume of 24 hour Urine

127

669

1.40

3.18

2.0

1.9

1737.20

1952.38

1.92

118

583

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

430

0.53

3.18

1.5

2.0

9.28

8.83

mg/l

0.21

360

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

136

0.27

3.17

1.2

1.9

0.94

1.76

mg/l

—

111

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

867

0.67

3.16

1.1

353.31

294.39

mg/l

0.83

782

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

140

751

1.37

3.15

2.2

41.32

136.69

ug/min

2.11

182

(4212803) Bone marrow aspirate examination

2.23

3.15

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

141

758

1.37

3.14

2.4

2.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

19609

145532

0.94

3.12

40.1

18.9

138.86

139.81

mmol/l

307.65

19373

142413

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.94

3.10

1.4

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

817

0.66

3.07

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

162

1.82

3.04

1.6

2.0

1.19

1.04

mmol/l

0.13

104

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

6.43

3.02

4.6

3.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

840

0.67

3.01

1.5

915.16

1014.68

mu/l

0.37

659

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

497

0.58

3.00

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

497

0.58

3.00

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

497

0.58

3.00

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

497

0.58

3.00

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

221

1281

1.27

2.92

2.2

2.3

750.88

665.26

1.48

130

881

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

111

1126

0.72

2.89

1.8

1.9

107.10

104.85

ng/l

0.11

111

1126

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

321

1943

1.22

2.88

2.1

33.87

25.76

mg/l

1.44

131

700

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

1030

0.71

2.87

2.1

1.7

453.75

336.91

mu/l

0.83

796

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

182

1718

0.78

2.86

1.2

24.48

46.38

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

415

0.55

2.86

1.4

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

158

1518

0.76

2.85

1.1

—

0.52

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

155

1490

0.76

2.81

1.1

1.73

1.51

iu/ml

—

(3045424) Erythrocytes [Presence] in Urine

1113

7411

1.11

2.74

3.2

2.0

0.04

0.13

estimate

0.35

267

2301

(3025018) Bordetella pertussis Ab [Titer] in Serum

795

0.68

2.71

1.2

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

528

0.61

2.71

1.3

1.4

56.87

57.47

0.03

463

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

698

0.66

2.70

1.2

1.1

—

1.00

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2231

15335

1.08

2.68

1.8

1.59

1.53

2.63

1898

13238

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

231

1.62

2.67

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

561

0.63

2.65

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.23

2.65

1.6

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4417

31053

1.06

2.62

1.2

1.3

2.27

1.72

u/ml

1.16

1071

8260

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

727

0.68

2.60

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

147

0.35

2.58

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.85

2.54

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

203

1860

0.80

2.53

1.2

1.3

28.98

58.75

u/ml

0.94

121

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

140

1.79

2.51

1.1

22.06

19.91

u/l

0.20

(3015076) Soybean IgE Ab [Units/volume] in Serum

471

0.61

2.50

1.1

1.0

0.28

1.05

u/ml

0.64

124

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

623

0.66

2.48

1.1

117.46

567.30

ng/l

1.08

164

(3029396) Erythrocyte agglutination [Presence] in Blood

2.11

2.48

2.0

2.8

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

523

4398

0.87

2.47

1.7

1.6

0.24

g/l

0.01

496

4190

(3007916) DNA double strand Ab [Titer] in Serum

190

0.39

2.47

1.2

1.3

—

184.76

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

109

1.89

2.45

1.4

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

332

2053

1.19

2.44

1.3

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

395

2480

1.17

2.43

1.4

1.3

13.61

9.31

u/l

5.90

314

1934

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

244

2179

0.82

2.40

1.1

1.2

3.64

11.81

u/ml

—

(3035320) C reactive protein [Mass/volume] in Body fluid

191

1118

1.26

2.40

2.9

2.8

37.47

30.21

mg/l

1.57

152

809

(3016750) Collection duration of Urine

159

910

1.29

2.39

2.2

492.63

500.13

min

0.39

101

688

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

14950

108198

1.04

2.39

4.3

4.6

17.61

12.20

mm/h

218.38

13787

100781

(3023419) Bacteria identified in Sputum by Culture

327

2028

1.19

2.34

2.5

2.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

424

3599

0.86

2.31

1.7

1.9

4.49

10.33

iu/l

0.99

146

1432

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

524

0.64

2.31

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

896

0.73

2.30

1.8

1.4

7.22

5.87

u/l

0.32

777

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

283

0.52

2.29

1.5

59.85

57.71

ug/l

0.08

283

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.17

2.27

1.7

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

645

0.68

2.27

1.1

1.73

1.09

u/l

0.58

288

(3002523) Influenza virus A Ag [Presence] in Specimen

190

1728

0.81

2.26

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

151

1409

0.79

2.25

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

357

0.58

2.25

3.4

8.48

7.58

mg/l

0.36

286

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1433

11354

0.92

2.25

2.2

2.3

12.19

15.13

nmol/l

30.92

1259

10357

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

196

1.61

2.24

1.2

74.68

100.12

ng/l

0.52

138

(3020874) Milk IgE Ab [Units/volume] in Serum

591

0.67

2.24

1.1

1.0

2.15

1.28

u/ml

0.25

197

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

540

4497

0.88

2.24

1.7

1.6

1.18

1.20

g/l

0.43

515

4283

(40762814) Titanium [Mass/volume] in Blood

347

0.57

2.23

2.4

2.6

3.32

3.53

ug/l

—

134

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

327

0.56

2.21

2.5

130.00

161.29

au/ml

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1141

0.77

2.21

1.1

1.2

—

(3034891) Synovial lining cells/cells in Synovial fluid

847

0.73

2.20

1.5

2.11

4.38

1.67

177

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

125

1190

0.77

2.20

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

364

1.43

2.18

1.8

1.9

230.09

187.66

2.12

343

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1139

0.77

2.18

1.1

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.30

2.16

1.1

1.0

234.93

304.82

nmol/l

0.82

(3038026) Centromere Ab [Units/volume] in Serum

131

1236

0.78

2.15

1.2

11.56

56.55

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

117

1119

0.77

2.14

1.1

1.2

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

187

0.43

2.13

1.1

1.0

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

2.05

2.12

1.4

1.2

0.07

g/l

0.19

(4027681) Cerebrospinal fluid IgG ratio and IgG index

635

0.69

2.11

1.3

1.2

0.61

0.55

ratio

0.59

389

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

235

1.53

2.09

1.1

1009.09

891.49

titre

0.21

(3014599) Egg white IgE Ab [Units/volume] in Serum

555

0.67

2.08

1.0

4.73

0.72

u/ml

0.53

136

(3018333) Ribosomal P Ab [Presence] in Serum

112

1072

0.77

2.07

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

114

1088

0.77

2.06

1.1

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

120

0.37

2.06

1.2

1.8

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

411

0.63

2.05

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

315

2705

0.85

2.05

1.3

1.6

13.43

17.37

u/ml

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.07

2.05

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

491

0.66

2.04

1.4

1.5

56.73

61.60

ug/l

0.20

386

(40759836) Histone Ab [Presence] in Serum by Immunoblot

124

1166

0.78

2.01

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

193

1727

0.82

2.00

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

298

1.46

1.99

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

947

0.76

1.97

1.1

1.0

4.88

7.13

nmol/l

0.30

171

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

370

2361

1.15

1.92

1.1

2731.51

5666.13

iu/ml

0.21

430

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.53

1.92

1.4

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.16

1.91

1.0

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

847

5687

1.10

1.87

2.0

1.7

0.33

0.32

mg/l

0.21

370

2784

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

158

936

1.24

1.87

1.3

31.04

34.22

u/l

0.52

125

684

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

104

1.77

1.85

1.0

1.1

7.75

17.13

iu/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

323

1.41

1.81

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

342

1.40

1.79

1.2

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

324

1.41

1.78

1.1

73.86

89.24

1.65

168

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

602

3988

1.11

1.76

2.5

2.3

130.09

109.62

ug/min

0.45

355

2302

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7891

56648

1.04

1.75

5.2

4.2

2.72

1.97

ug/l

7.02

6950

51505

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

128

749

1.26

1.71

3.8

4.0

—

(3033099) Centromere Ab [Titer] in Serum

401

0.66

1.71

1.0

1.1

—

(3024263) Appearance of Synovial fluid

860

0.77

1.71

1.4

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

296

1.42

1.71

1.5

1.6

99.20

116.71

ug/l

0.84

249

(3028433) Virus identified in Specimen by Culture

393

1.35

1.62

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

664

1.26

1.61

1.0

—

(40757373) Influenza virus identified in Isolate

263

1.43

1.60

1.5

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.37

1.59

2.0

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

353

2282

1.14

1.59

1.2

51.39

20.07

u/l

2.27

313

1957

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

156

943

1.22

1.58

1.2

—

(3025130) Human papilloma virus identified in Specimen

149

1329

0.82

1.57

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

453

0.70

1.56

1.3

1.4

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

1.56

0.0

5.9

—

0.26

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

320

0.64

1.53

1.3

1.7

131.62

95.08

au/ml

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

398

1.33

1.51

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

561

0.73

1.51

1.2

1.1

32.50

6.81

u/ml

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

155

1371

0.83

1.51

1.6

1.9

662.86

2798.79

titre

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

153

929

1.21

1.50

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

457

0.71

1.49

1.3

1.4

1.00

0.95

ratio

0.19

266

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

457

0.71

1.49

1.3

1.4

1.06

1.18

ratio

0.29

266

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

457

0.71

1.49

1.3

1.4

0.98

1.22

ratio

0.99

266

(3028679) Herpes simplex virus Ab [Presence] in Serum

592

0.74

1.48

1.1

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

775

0.78

1.47

5.3

5.8

277.50

5177.84

u/ml

0.51

132

(3051101) Glucose [Moles/volume] in Cord blood

352

0.67

1.47

5.6

6.0

9.05

8.56

mmol/l

0.45

352

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.44

1.47

1.2

85.26

86.96

0.08

(3011985) Renin [Units/volume] in Plasma

336

2179

1.14

1.46

1.4

69.75

61.90

mu/l

0.24

300

1953

(4024509) Urine culture

952

7513

0.93

1.45

2.1

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

673

0.76

1.44

1.3

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

0.50

1.42

1.2

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

296

0.65

1.42

1.0

1.1

5.33

8.78

u/ml

0.66

168

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

529

0.74

1.42

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

227

1.43

1.41

1.1

1.2

81.75

76.71

0.20

(3000034) Microalbumin [Mass/volume] in Urine

226

1430

1.16

1.41

3.1

3.0

36.97

41.66

mg/l

0.15

162

1020

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

0.90

2.28

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

2.99

1.95

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

0.86

2.72

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

0.21

0.77

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

1.91

3.39

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

0.27

0.95

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.94

1.40

1.6

1.4

0.20

1.68

mg/l

—

(3026470) Cobalt [Mass/volume] in Blood

129

1151

0.82

1.40

2.1

2.2

3.51

3.57

ug/l

0.04

115

1076

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

627

0.76

1.38

1.0

1.1

1494.86

1603.60

miu/ml

0.35

627

(3023323) Follitropin [Units/volume] in Serum or Plasma

368

3026

0.89

1.37

1.3

37.67

32.67

iu/l

1.62

296

2618

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.37

0.0

2.8

—

35.11

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.87

1.36

1.1

1.4

1.00

1.03

u/field

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

669

4524

1.09

1.35

1.4

1.5

14.18

16.98

iu/ml

0.16

108

(3043238) Trisomy 21 risk [Likelihood] in Fetus

396

0.70

1.34

1.4

1.5

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

309

0.67

1.33

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

689

0.78

1.33

1.1

20.09

21.24

u/ml

0.12

242

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

9279

67023

1.03

1.32

2.6

2.4

75.16

78.66

nmol/l

25.54

8398

59548

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

182

0.56

1.32

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

144

0.51

1.31

1.2

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

488

0.74

1.31

1.2

1.3

114.79

136.87

nmol/l

0.70

336

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

129

0.51

1.31

1.0

5.79

9.49

u/ml

—

129

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.16

1.30

1.5

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.76

1.30

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

585

1.24

1.30

5.0

6.5

24.70

25.30

mmol/l

0.52

531

(3032868) Hemoglobin electrophoresis panel in Blood

101

0.44

1.29

1.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

311

2028

1.13

1.28

1.2

1.3

334.37

340.94

pmol/l

0.04

265

1694

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.87

1.28

1.6

1.4

0.70

1.43

mg/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

120

725

1.22

1.28

1.1

5.33

4.29

iu/ml

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

320

1.33

1.28

2.7

2.6

7.51

7.83

mmol/l

0.27

197

(3005033) Fetal Nuchal fold Thickness US

375

0.70

1.28

1.4

1.31

1.28

0.05

250

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

219

1396

1.15

1.27

1.1

1.2

96.76

96.98

0.04

202

1302

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

2.83

1.26

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

286

0.67

1.24

1.4

2.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

148

1.49

1.23

2.1

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

697

0.79

1.23

1.1

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

214

0.62

1.22

1.1

1.3

41.00

49.27

—

(3025577) Chromium [Mass/volume] in Blood

126

1108

0.83

1.22

2.2

2.16

2.35

ug/l

0.29

925

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

371

0.71

1.21

2.0

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

379

0.72

1.21

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

274

1.34

1.17

2.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

211

0.63

1.16

1.1

1.3

3.72

6.94

mmol/l

—

105

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.75

1.14

1.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

201

0.62

1.14

1.1

1.2

—

80.62

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

200

1.40

1.14

1.2

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

297

1950

1.12

1.13

1.2

3.91

3.80

u/ml

0.04

127

729

(3036670) Protein [Mass/volume] in Synovial fluid

556

0.78

1.11

1.2

1.3

39.66

40.31

g/l

0.12

294

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

199

0.63

1.10

1.0

1.1

50.77

32.87

iu/ml

0.41

199

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

196

1.39

1.08

2.4

2.8

0.78

0.55

u/field

0.67

196

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.07

1.07

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

110

675

1.20

1.05

3.6

3.3

—

(3012898) Urea [Moles/volume] in Urine

160

1.42

1.05

1.2

1.4

195.55

162.16

mmol/l

0.44

143

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

261

1.32

1.04

1.1

1.2

—

(3044927) Protein electrophoresis panel - Urine

262

1719

1.12

1.03

1.2

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

451

0.77

1.03

1.3

35.85

38.15

0.16

304

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

112

1.51

1.03

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

281

1.31

1.02

1.9

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.06

1.01

4.9

2.0

—

(3041184) Isoniazid [Presence] in Urine

2.30

1.01

2.0

2.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

185

0.64

1.00

1.1

1.2

—

(44806420) Estimation of glomerular filtration rate

165

1391

0.87

0.99

2.6

2.7

—

(3034614) HLA Ag [Interpretation]

0.00

0.99

0.0

1.1

—

(4211845) Urine protein measurement

118

735

1.18

0.98

3.5

3.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

172

1104

1.15

0.97

1.3

1.2

109.54

104.04

pmol/l

0.66

172

1104

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.98

0.97

4.9

2.2

—

236683.33

—

(3003577) Lead [Moles/volume] in Blood

0.50

0.96

1.0

1.4

—

0.15

—

(3018291) Platelet Ab [Presence] in Serum

2.32

0.95

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

567

0.80

0.94

1.4

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

137

0.59

0.94

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

390

1.24

0.93

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.52

0.93

1.5

1.4

22.43

22.44

mmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.66

0.92

2.2

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

104

1.48

0.89

1.2

1.3

0.13

0.18

nmol/l

0.72

(4268621) Lupus anticoagulant assay

205

1341

1.12

0.89

2.2

2.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

141

1.41

0.89

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

707

0.83

0.89

1.1

1.2

1.06

1.07

ratio

0.21

579

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

562

0.81

0.88

2.7

3.0

30.67

28.53

umol/l

0.84

423

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

507

1.20

0.88

1.8

213.16

166.31

3.23

474

(3001729) Color of Synovial fluid

134

0.60

0.88

1.2

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

205

1.33

0.86

3.5

2.6

25.04

51.17

mg/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

335

1.25

0.86

1.1

76.90

88.53

1.27

171

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

142

1.40

0.86

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

142

1.40

0.86

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

133

0.61

0.85

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

355

0.77

0.85

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

0.62

0.81

1.1

6.21

6.35

mmol/l

0.21

131

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

110

0.60

0.80

1.6

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

209

0.70

0.80

1.3

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

287

1927

1.10

0.79

1.2

2.64

3.96

u/ml

3.11

143

897

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

132

1.39

0.79

2.4

1.6

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.51

0.79

7.5

6.8

11.06

7.54

1.18

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.51

0.79

3.8

3.4

28.76

47.01

3.08

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

208

0.71

0.78

1.8

2.0

18.18

17.83

umol/l

0.06

208

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.78

0.0

1.0

—

3516.29

—

(36660697) Celiac disease serology panel - Serum

1556

11024

1.04

0.78

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

407

1.21

0.77

1.2

1.3

2.40

3.19

umol/l

1.58

350

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

267

1790

1.10

0.77

1.1

112.91

117.08

1.45

248

1606

(3039744) RNA polymerase III Ab [Units/volume] in Serum

120

0.61

0.77

1.0

—

3.77

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

401

1.21

0.76

7.3

6.6

63.42

70.34

0.84

325

(3033942) Copper [Moles/time] in 24 hour Urine

1.63

0.76

1.5

1.0

2.24

0.53

umol/24h

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

146

1.36

0.75

1.0

1.2

—

(3022621) pH of Urine by Test strip

1585

12064

0.96

0.75

3.0

2.7

6.03

6.04

0.11

1211

8320

(3045462) Protein/Creatinine [Ratio] in Urine

121

1.40

0.75

3.4

4.7

168.05

57.95

mg/mmol

0.43

115

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.60

0.75

1.1

1.0

0.06

0.03

u/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

842

5893

1.05

0.73

1.2

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

238

0.74

0.72

1.5

1.2

46.99

43.06

mg/l

0.14

204

(3024869) Neuronal Ab [Presence] in Serum

251

1.26

0.72

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

594

1.16

0.72

1.6

1.2

39.10

39.71

g/l

0.45

594

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

1.93

0.70

1.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

507

3957

0.94

0.69

1.8

2.1

12.90

11.73

mg/l

1.40

467

3697

(3042517) Benzodiazepines panel - Urine

0.52

0.68

1.0

2.7

—

(3027874) Urate [Moles/volume] in Urine

1.54

0.68

1.5

1.0

1.89

1.64

mmol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

143

936

1.12

0.67

1.4

0.31

0.26

nmol/l

0.39

664

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

982

6922

1.04

0.66

1.1

6.24

9.21

u/ml

0.16

(3006653) Thiamine [Moles/volume] in Blood

122

792

1.13

0.66

1.1

1.2

131.07

138.42

nmol/l

0.95

122

792

(3023410) Appearance of Cerebral spinal fluid

165

1345

0.90

0.66

1.4

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

493

0.83

0.65

1.1

92.85

99.80

0.91

383

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

822

6318

0.95

0.65

1.7

2.0

40.64

39.34

u/l

0.95

734

5507

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

295

2340

0.93

0.65

1.2

1.3

166.17

211.78

miu/ml

1.19

927

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.61

0.65

1.7

1.8

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.75

0.64

2.4

2.0

24.02

30.44

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

221

1486

1.09

0.64

1.0

1.1

5.16

4.17

eliau/ml

0.28

590

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

151

1.31

0.63

1.1

1.0

80.54

81.95

ug/l

0.07

109

(3009871) Measles virus Ab [Titer] in Serum

499

0.84

0.63

1.6

3976.00

4013.00

titre

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.58

0.63

18.8

11.4

556.50

145.94

e6/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

435

0.83

0.63

1.3

1.6

12.43

9.28

ug/l

2.11

435

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

122

0.66

0.63

1.1

130.91

89.70

titre

0.48

122

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

0.07

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6080

45292

0.98

0.61

4.3

3.9

21.54

24.19

36.41

3112

21286

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

441

0.83

0.61

1.1

1.2

20.86

25.43

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.60

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.60

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.60

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.60

0.0

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

301

2063

1.07

0.57

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

119

782

1.12

0.56

1.9

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

362

1.18

0.55

1.2

1.1

15.07

12.46

pmol/l

0.37

145

(3002079) Sodium [Moles/time] in 24 hour Urine

686

0.88

0.54

1.2

156.20

167.15

mmol/24h

0.49

686

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

151

1217

0.91

0.52

1.3

199.09

524.62

titre

1.33

106

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4410

32895

0.98

0.52

3.1

2.9

0.79

0.70

ug/l

4.99

3100

21464

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

204

1.23

0.50

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

179

1426

0.92

0.49

1.4

1.6

24.00

25.70

u/ml

0.19

310

(3020911) Cortisol [Moles/time] in 24 hour Urine

429

1.15

0.49

1.4

674.54

78.30

nmol/24h

1.22

429

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

185

1.23

0.48

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

302

0.83

0.48

2.2

1.8

—

(3036048) Francisella tularensis Ab [Titer] in Serum

302

0.83

0.48

1.0

1.2

—

337.50

—

(40761535) Cells panel - Urine sediment

1688

12109

1.03

0.46

3.6

3.4

—

1.70

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

645

0.89

0.45

1.2

64.78

53.98

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

138

0.75

0.45

1.4

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

1.39

0.44

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

267

0.83

0.44

1.1

1.0

0.88

1.04

u/ml

0.11

131

(3001218) Citrate [Mass/time] in 24 hour Urine

1.67

0.44

2.0

1.5

259.00

417.09

mg/24h

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

106

705

1.11

0.44

1.6

1.8

129.61

110.38

umol/l

0.20

344

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

202

0.80

0.43

1.2

1.1

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

0.42

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.42

0.0

1.2

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.42

0.0

1.3

—

29.45

—

(3017400) Magnesium [Moles/volume] in Urine

1.53

0.41

1.2

1.0

2.88

2.49

mmol/l

—

(37021550) Renin [Units/volume] in Plasma --upright

277

1.17

0.41

1.1

1.3

161.57

59.03

mu/l

1.14

197

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

111

0.73

0.41

1.0

1.1

—

(3019174) dRVVT (LA screen)

111

0.73

0.41

1.1

1.2

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.41

0.0

1.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

109

1.28

0.41

1.2

1.1

10.89

10.81

u/l

0.01

109

(3046861) Legionella sp Ag [Presence] in Urine

1.33

0.41

1.2

1.1

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

15464

113146

1.01

0.40

43.2

18.3

14.73

13.62

307.65

15358

111407

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.31

0.40

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

137

930

1.08

0.39

2.3

2.2

16.70

16.10

nmol/l

0.37

126

855

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

307

2144

1.05

0.38

1.5

1.6

—

(44806071) Cardiolipin IgM antibody measurement

190

0.81

0.37

1.0

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.30

0.37

1.1

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

449

0.88

0.37

1.4

1.2

0.32

0.31

g/l

0.28

366

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

871

6585

0.97

0.36

1.0

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

353

2715

0.95

0.36

1.9

4.54

4.94

mmol/24h

1.31

308

2398

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

100

672

1.09

0.36

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

118

1.25

0.36

1.3

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.62

0.36

4.8

5.7

—

(4146454) Self-monitoring of blood glucose

289

2020

1.05

0.35

2.8

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.38

0.35

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

107

0.76

0.34

1.3

1.4

28.60

45.69

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.69

0.33

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.68

0.33

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

336

0.87

0.33

1.0

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

1.26

0.33

1.2

1.1

41.27

54.34

u/l

0.42

(4133840) Spirometry

367

0.88

0.33

1.4

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

140

1.21

0.33

2.0

1.7

48.39

47.30

umol/l

0.07

140

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

267

1869

1.05

0.32

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

151

1182

0.94

0.31

1.2

1.3

122.86

78.10

titre

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.72

0.31

1.6

1.5

0.41

0.50

e9/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

182

1.17

0.31

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

2099

15189

1.02

0.30

2.8

2.0

0.01

estimate

0.39

367

3001

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

203

1.16

0.30

1.0

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

426

0.90

0.30

1.3

1.2

107.71

113.43

1.04

379

(40765089) Chromosome analysis panel - Blood by G-banded

101

1.24

0.30

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

335

1.12

0.30

1.1

1.2

369.90

275.21

pmol/l

0.66

237

(3020491) Glucose [Moles/volume] in Blood

147

1015

1.06

0.29

1.8

2.0

7.64

7.05

mmol/l

1.26

110

689

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

437

3102

1.04

0.29

1.2

1.3

310.37

323.59

titre

0.04

259

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

486

0.91

0.29

1.2

15.73

10.76

mm/h

1.52

486

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

465

3307

1.03

0.28

1.1

4.60

9.52

eliau/ml

2.06

333

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.74

0.27

1.1

1.2

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.25

0.27

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.27

1.0

1.1

—

(40768443) Skin Pathology biopsy report

852

6124

1.02

0.26

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

473

1.09

0.26

1.5

14.62

15.94

pmol/l

1.34

393

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

219

1541

1.04

0.24

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

0.72

0.24

1.0

1.2

207.50

267.43

u/l

—

(3017704) Immunofixation for Urine

118

817

1.06

0.24

1.3

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.36

0.24

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

208

1.13

0.23

1.1

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

156

0.85

0.23

1.2

1.7

7.93

7.05

mmol/l

0.34

(3033923) Metanephrine [Moles/time] in 24 hour Urine

311

0.90

0.23

1.1

0.65

0.68

umol/24h

0.22

141

(3013247) Albumin in CSF/Albumin in Serum or Plasma

187

0.86

0.23

1.1

9.72

8.22

mg/g

0.25

177

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

349

0.91

0.23

5.8

7.0

10.33

10.44

0.15

349

(3051387) C reactive protein [Mass/volume] in Capillary blood

432

3264

0.97

0.22

3.7

3.5

34.70

26.22

mg/l

4.65

314

2317

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

194

0.87

0.22

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

0.80

—

(40762887) Creatinine [Moles/volume] in Blood

126

1.17

0.22

1.8

1.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.03

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.76

0.21

4.8

3.3

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.26

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

8062

58960

1.01

0.20

4.7

4.0

0.25

0.49

estimate

0.74

2210

12450

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

190

1.12

0.20

1.1

1.4

8.30

298757.69

nmol/l

1.34

160

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.19

0.19

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

459

0.93

0.19

1.0

1.1

—

(3034426) Prothrombin time (PT)

381

1.08

0.19

1.2

28.20

28.31

0.04

381

(3044009) aPTT.lupus sensitive (LA screen)

106

0.83

0.19

1.1

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

219

1553

1.04

0.19

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.82

0.19

1.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

555

1.06

0.17

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

592

0.94

0.17

2.5

2.3

55.56

53.73

umol/l

0.19

498

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.71

0.17

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

394

0.93

0.16

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

0.79

0.14

1.0

1.2

76.29

83.32

umol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

369

0.94

0.14

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

141

0.89

0.14

1.2

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

5565

40715

1.01

0.13

3.2

2.5

357.58

353.12

umol/l

2.16

4857

35322

(3017509) Phencyclidine [Presence] in Urine

0.84

0.13

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

420

0.94

0.13

1.6

0.40

0.35

ug/l

0.35

284

(4195642) Thrombophilia screening test

251

1801

1.02

0.13

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

117

0.88

0.13

1.1

—

0.40

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.16

0.12

11.8

8.5

99.25

104.92

g/l

1.02

(40768446) Kidney Pathology biopsy report

584

1.04

0.12

1.3

1.6

—

(4015189) Microbial culture of sputum

434

0.95

0.12

1.8

2.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

347

1.06

0.12

1.4

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

492

1.05

0.11

7.0

7.4

5.73

6.04

kpa

2.64

440

(3005011) Chlamydia sp Ab [Titer] in Serum

169

0.91

0.11

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1092

7950

1.01

0.11

3.2

3.1

4.27

4.43

pmol/l

6.50

971

7027

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

364

0.95

0.10

1.0

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

179

1285

1.02

0.10

1.4

1.5

0.76

1.28

promille

5.89

146

996

(3021387) Prolactin [Units/volume] in Serum or Plasma

347

2590

0.98

0.09

2.3

1.8

327.25

289.45

mu/l

0.66

325

2380

(4198724) Urine methamphetamine measurement

348

0.95

0.09

1.4

2.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.05

0.09

1.2

1.1

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.05

0.09

1.0

1.6

—

2196.67

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

142

1.09

0.09

2.1

2.3

0.62

0.64

ug/l

0.12

142

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.89

0.09

1.1

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

167

0.92

0.09

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.78

0.08

1.2

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

186

1.07

0.08

3.1

2.3

41.05

41.48

umol/l

0.03

159

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

0.89

0.08

1.1

1.4

5.20

1.08

—

(3020650) Glucose [Presence] in Urine

454

1.04

0.07

1.5

1.7

0.00

0.06

estimate

2.72

454

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

143

0.92

0.07

1.2

1.1

1.42

1.72

umol/24h

1.06

143

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.84

0.07

1.1

1.3

1.43

1.36

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.83

0.07

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

710

1.02

0.06

1.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

336

0.96

0.06

1.1

1.2

0.92

50.80

mg/l

1.24

248

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

102

735

1.02

0.05

1.2

1.6

—

(3003129) Base excess in Capillary blood by calculation

267

1982

0.99

0.05

2.8

2.0

0.30

0.63

mmol/l

0.61

256

1919

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

103

743

1.02

0.04

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

255

1.04

0.04

1.6

1.2

153.83

244.85

titre

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

193

1435

0.99

0.04

1.2

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1400

10321

1.00

0.04

1.2

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

814

6007

1.00

0.04

1.1

210.74

184.85

titre

0.19

157

(3036525) Urea [Moles/time] in 24 hour Urine

1.07

0.03

3.1

3.0

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

942

6902

1.00

0.02

1.4

1.6

15.00

16.68

iu/ml

0.12

154

(43055514) Macroprolactin [Presence] in Serum or Plasma

170

1.04

0.02

1.3

1.5

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

142

1.03

0.01

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

341

1.01

0.00

1.2

1.4

1.16

1.18

mmol/l

0.79

341

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.95

0.00

2.1

1.4

464.36

317.01

umol/24h

0.59

(3038071) Oxygen [Partial pressure] in Mixed venous blood

440

1.00

0.00

7.2

5.67

5.31

kpa

0.58

440

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.97

0.00

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

421

0.99

0.00

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

104

0.99

0.00

3.4

2.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

196

1.01

0.00

1.0

1.2

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.60

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

28.40

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.90

-0.00

1.0

1.2

—

mmol/l

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

89.50

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.94

-0.00

1.0

1.1

—

29.88

—

(3018487) Sunflower Seed IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.06

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.90

-0.00

1.6

1.5

701.78

537.03

nmol/l

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.92

-0.00

8.8

8.2

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

1.48

—

(3015057) Respiratory syncytial virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.95

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_DIGESTIVE_ORGANS_WIDE – Malignant neoplasm of digestive organs, including Hilmo

GWS hits: 19

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of digestive organs, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints